RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | Lung Neoplasms |
|
Accession: | DOID:9005172
|
browse the term
|
Definition: | Tumors of the LUNG. |
Synonyms: | exact_synonym: | lung neoplasm; pulmonary neoplasm; pulmonary neoplasms |
| related_synonym: | CYP2A6*4A |
| primary_id: | MESH:D008175 |
|
|
|
G |
A2m |
alpha-2-macroglobulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17902193 PMID:19180532 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Ace |
angiotensin I converting enzyme |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Acsm1 |
acyl-CoA synthetase medium-chain family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17114358 |
|
NCBI chr 1:173,985,715...174,020,565
Ensembl chr 1:173,984,672...174,025,495
|
|
G |
Actb |
actin, beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23692979 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Ada |
adenosine deaminase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:2305558 |
|
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
|
|
G |
Adam28 |
ADAM metallopeptidase domain 28 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20544843 |
|
NCBI chr15:43,774,463...43,840,726
Ensembl chr15:42,944,467...43,840,672
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
ISO |
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:12511591 PMID:21911043 PMID:22619562 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alox12 |
arachidonate 12-lipoxygenase, 12S type |
|
ISO |
|
RGD |
PMID:7511046 |
RGD:2313872 |
NCBI chr10:54,958,263...54,970,542
Ensembl chr10:54,958,271...54,970,542
|
|
G |
Alx4 |
ALX homeobox 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24037716 |
|
NCBI chr 3:79,611,682...79,648,260
Ensembl chr 3:79,611,719...79,648,260
|
|
G |
Ank3 |
ankyrin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr20:18,602,267...19,225,831
Ensembl chr20:18,602,786...19,086,300
|
|
G |
Anxa2 |
annexin A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20682992 |
|
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18337602 |
|
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19180532 |
|
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Apoc3 |
apolipoprotein C3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19180532 |
|
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19180532 PMID:20430468 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Ar |
androgen receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30008631 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arhgef5 |
Rho guanine nucleotide exchange factor 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29054765 |
|
NCBI chr 4:72,087,205...72,112,316
Ensembl chr 4:72,087,247...72,111,254
|
|
G |
As3mt |
arsenite methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:36399430 |
|
NCBI chr 1:245,595,939...245,628,921
Ensembl chr 1:245,596,108...245,627,872
|
|
G |
Atg101 |
autophagy related 101 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr 7:132,398,477...132,407,643
Ensembl chr 7:132,398,483...132,407,633
|
|
G |
Atox1 |
antioxidant 1 copper chaperone |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23624903 |
|
NCBI chr10:39,564,855...39,579,892
Ensembl chr10:39,564,857...39,579,950
|
|
G |
Avpi1 |
arginine vasopressin-induced 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr 1:240,930,236...240,936,154
Ensembl chr 1:240,930,236...240,936,154
|
|
G |
Azgp1 |
alpha-2-glycoprotein 1, zinc-binding |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18978557 |
|
NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26719535 |
|
NCBI chr16:6,446,709...6,455,535
Ensembl chr16:6,446,709...6,455,535
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16007126 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Becn1 |
beclin 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:22481206 PMID:23790316 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr 4:178,834,264...178,838,618
Ensembl chr 4:178,834,271...178,838,468
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:15981204 PMID:16108013 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
|
|
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24880342 |
|
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
|
|
G |
Calml3 |
calmodulin-like 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr17:66,419,844...66,423,083
Ensembl chr17:66,419,882...66,423,175
|
|
G |
Car12 |
carbonic anhydrase 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
|
|
G |
Casp7 |
caspase 7 |
disease_progression |
ISO |
|
RGD |
PMID:23979166 |
RGD:13209143 |
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17450141 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Cav1 |
caveolin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29247004 |
|
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
|
|
G |
Cbr2 |
carbonyl reductase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18597497 |
|
NCBI chr10:106,008,535...106,012,838
Ensembl chr10:105,991,589...106,013,001
|
|
G |
Cbx5 |
chromobox 5 |
|
ISO |
|
RGD |
PMID:22900142 |
RGD:9586743 |
NCBI chr 7:134,333,165...134,376,102
Ensembl chr 7:134,331,335...134,375,022
|
|
G |
Cbx7 |
chromobox 7 |
|
ISO |
protein:decreased expression:lung (human) |
RGD |
PMID:22214847 PMID:22214847 |
RGD:9587356, RGD:9587356 |
NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973
|
|
G |
Ccn1 |
cellular communication network factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccn2 |
cellular communication network factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccnd1 |
cyclin D1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11307925 PMID:16289808 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccng1 |
cyclin G1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16289808 |
|
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Cd274 |
CD274 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27692344 PMID:34166680 |
|
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
|
|
G |
Cdc5l |
cell division cycle 5-like |
|
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:14647414 |
RGD:10047051 |
NCBI chr 9:15,564,949...15,603,453
Ensembl chr 9:15,564,767...15,603,450
|
|
G |
Cdh13 |
cadherin 13 |
|
IDA ISO |
associated with Inflammation;DNA:hypermethylation:promoter CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18337602 PMID:17971904 PMID:9737784 |
RGD:2293546, RGD:734736 |
NCBI chr19:46,349,562...47,387,462
Ensembl chr19:46,349,430...47,387,459
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12466968 PMID:18508827 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12466968 PMID:16391232 PMID:20512841 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20512841 PMID:21552421 |
|
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
IDA ISO |
DNA:hypermethylation:promoter CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:11872642 PMID:12115568 PMID:18337602 PMID:20135361 PMID:11872642 PMID:19409458 More...
|
RGD:1298567, RGD:7248761 |
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Ceacam1 |
CEA cell adhesion molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
|
|
G |
Ces1d |
carboxylesterase 1D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17114358 PMID:17311802 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Chd4 |
chromodomain helicase DNA binding protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30008631 |
|
NCBI chr 4:157,898,503...157,931,632
Ensembl chr 4:157,899,391...157,931,541
|
|
G |
Chek2 |
checkpoint kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24880342 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Chrna2 |
cholinergic receptor nicotinic alpha 2 subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28604730 |
|
NCBI chr15:40,342,317...40,358,601
Ensembl chr15:40,342,317...40,358,601
|
|
G |
Chrna3 |
cholinergic receptor nicotinic alpha 3 subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18385738 |
|
NCBI chr 8:55,401,668...55,415,165
Ensembl chr 8:55,401,702...55,415,165
|
|
G |
Chrna5 |
cholinergic receptor nicotinic alpha 5 subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18385738 |
|
NCBI chr 8:55,369,794...55,398,526
Ensembl chr 8:55,369,794...55,398,146
|
|
G |
Chrna7 |
cholinergic receptor nicotinic alpha 7 subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24089524 |
|
NCBI chr 1:116,711,559...116,837,269
Ensembl chr 1:116,714,711...116,837,240
|
|
G |
Chrnb4 |
cholinergic receptor nicotinic beta 4 subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18385738 |
|
NCBI chr 8:55,417,583...55,437,027
Ensembl chr 8:55,418,313...55,437,027
|
|
G |
Chst15 |
carbohydrate sulfotransferase 15 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr 1:187,028,860...187,107,908
Ensembl chr 1:187,028,970...187,107,707
|
|
G |
Clca2 |
chloride channel accessory 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr 2:233,993,619...234,022,691
Ensembl chr 2:233,995,078...234,022,199
|
|
G |
Clptm1l |
CLPTM1-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18978787 PMID:19151717 PMID:23433592 PMID:24366883 |
|
NCBI chr 1:29,667,545...29,683,530
Ensembl chr 1:29,667,545...29,683,530
|
|
G |
Cltb |
clathrin, light chain B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr17:10,001,512...10,019,201
Ensembl chr17:10,001,513...10,019,169
|
|
G |
Col6a1 |
collagen type VI alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23692979 |
|
NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,957...11,924,597
|
|
G |
Cox17 |
cytochrome c oxidase copper chaperone COX17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23624903 |
|
NCBI chr11:62,400,733...62,406,507
|
|
G |
Cpe |
carboxypeptidase E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233
|
|
G |
Crp |
C-reactive protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17114654 |
|
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18372914 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cwh43 |
cell wall biogenesis 43 C-terminal homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr14:34,754,279...34,800,530
Ensembl chr14:34,754,289...34,800,814
|
|
G |
Cxcl14 |
C-X-C motif chemokine ligand 14 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20562917 |
|
NCBI chr17:8,317,930...8,325,956
Ensembl chr17:8,317,933...8,324,839
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22072123 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11376689 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22797725 |
|
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:1673675 PMID:17093202 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Dab2ip |
DAB2 interacting protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22046421 |
|
NCBI chr 3:18,915,290...19,086,282
Ensembl chr 3:18,915,290...19,086,280
|
|
G |
Dapk1 |
death associated protein kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15172992 |
|
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
|
|
G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
|
|
G |
Dnai7 |
dynein axonemal intermediate chain 7 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15064703 PMID:16862160 |
RGD:11340955 |
NCBI chr 4:178,143,499...178,179,871
Ensembl chr 4:178,143,500...178,179,980
|
|
G |
Dnase1l3 |
deoxyribonuclease 1L3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21720004 |
|
NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26192916 |
|
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
|
|
G |
Dok1 |
docking protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20139980 |
|
NCBI chr 4:115,537,453...115,540,464
Ensembl chr 4:115,537,462...115,540,465
|
|
G |
Dok2 |
docking protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20139980 |
|
NCBI chr15:45,826,984...45,841,409
Ensembl chr15:45,827,398...45,841,402
|
|
G |
Dok3 |
docking protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20139980 |
|
NCBI chr17:9,109,633...9,115,188
Ensembl chr17:9,109,597...9,115,188
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19020767 |
|
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
|
|
G |
Eaf2 |
ELL associated factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20564326 |
|
NCBI chr11:63,960,200...64,004,610
Ensembl chr11:63,960,200...64,004,610
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21554491 |
|
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
|
|
G |
Efemp1 |
EGF containing fibulin extracellular matrix protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17671114 |
|
NCBI chr14:102,610,813...102,690,027
Ensembl chr14:102,610,908...102,690,018
|
|
G |
Efnb2 |
ephrin B2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr16:80,783,389...80,827,420
Ensembl chr16:80,783,417...80,824,391
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
protein:increased expression:tumor (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18927287 PMID:19336973 PMID:20934974 PMID:21541241 PMID:23523951 PMID:27935865 PMID:29106415 PMID:11894009 More...
|
RGD:5131628 |
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egr1 |
early growth response 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Ehmt2 |
euchromatic histone lysine methyltransferase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20940408 |
|
NCBI chr20:3,919,623...3,936,751
Ensembl chr20:3,919,624...3,941,547
|
|
G |
Emx2 |
empty spiracles homeobox 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20697358 |
|
NCBI chr 1:258,626,584...258,633,594
Ensembl chr 1:258,626,584...258,633,594
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17114358 PMID:17311802 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12483526 |
|
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12483526 |
|
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30453383 |
|
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
susceptibility |
ISO |
DNA:haplotype:cds:p.K751Q(human) |
GAD RGD |
PMID:15118671 PMID:17498557 |
RGD:1331525, RGD:12880386 |
NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102
|
|
G |
Ercc3 |
ERCC excision repair 3, TFIIH core complex helicase subunit |
susceptibility |
ISO |
DNA:snps, haplotype:introns:c.43-61A>G, c.1151-2708A>G, (rs2271026, rs4150441) (human) |
RGD |
PMID:16835333 |
RGD:13207447 |
NCBI chr18:23,883,613...23,914,326
Ensembl chr18:23,883,580...23,914,329
|
|
G |
Ercc6 |
ERCC excision repair 6, chromatin remodeling factor |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNPs: :rs3793784, rs12571445 (human) |
CTD RGD |
PMID:17854076 PMID:18789574 |
RGD:11567231 |
NCBI chr16:7,764,983...7,835,587
Ensembl chr16:7,765,013...7,835,587
|
|
G |
Ergic3 |
ERGIC and golgi 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27588471 |
|
NCBI chr 3:144,525,059...144,534,813
Ensembl chr 3:144,525,092...144,534,813
|
|
G |
Esr1 |
estrogen receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11872642 PMID:17077188 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26192916 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
|
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fen1 |
flap structure-specific endonuclease 1 |
|
ISO |
DNA:missense mutation:cds:p.E160D CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:28371273 PMID:17589521 |
RGD:6484213 |
NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
|
|
G |
Fgf9 |
fibroblast growth factor 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20464547 |
|
NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21936542 |
|
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17311802 |
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fhit |
fragile histidine triad diadenosine triphosphatase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10959838 PMID:16061637 |
|
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16289808 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosb |
FosB proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
|
|
G |
Fosl2 |
FOS like 2, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034
|
|
G |
Foxm1 |
forkhead box M1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16489016 PMID:23255470 |
|
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
|
|
G |
Foxp3 |
forkhead box P3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34166680 |
|
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
|
|
G |
Fubp1 |
far upstream element binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35915169 |
|
NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
|
|
G |
Gast |
gastrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11208460 |
|
NCBI chr10:85,264,832...85,269,393
Ensembl chr10:85,264,832...85,267,496
|
|
G |
Gata6 |
GATA binding protein 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16271038 |
|
NCBI chr18:2,188,121...2,219,532
Ensembl chr18:2,188,121...2,219,532
|
|
G |
Gc |
GC, vitamin D binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17902193 |
|
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Ggt5 |
gamma-glutamyltransferase 5 |
|
IEP |
mRNA:increased expression:lung |
RGD |
PMID:9374738 |
RGD:69846 |
NCBI chr20:13,043,255...13,071,523
Ensembl chr20:13,043,257...13,071,450
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15166089 PMID:16926031 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15492231 PMID:16926031 |
|
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11103801 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19180532 PMID:21552421 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Grb7 |
growth factor receptor bound protein 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr10:83,443,387...83,453,057
Ensembl chr10:83,444,004...83,453,052
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17114358 PMID:17311802 PMID:22072123 PMID:24852519 PMID:15118671 |
RGD:1331525 |
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
|
ISO |
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17909032 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17000715 PMID:24852519 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17804716 |
|
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Hey1 |
hes-related family bHLH transcription factor with YRPW motif 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17804716 |
|
NCBI chr 2:93,096,605...93,100,316
Ensembl chr 2:93,095,498...93,100,312
|
|
G |
Hilpda |
hypoxia inducible lipid droplet-associated |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15688187 PMID:18508827 PMID:31227482 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10779650 PMID:11307925 PMID:11552296 PMID:12765245 PMID:15902970 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Htra1 |
HtrA serine peptidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
|
|
G |
Id3 |
inhibitor of DNA binding 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
|
|
G |
Ids |
iduronate 2-sulfatase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr X:149,025,976...149,046,641
Ensembl chr X:149,025,976...149,046,663
|
|
G |
Ier2 |
immediate early response 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr19:23,494,551...23,496,075
Ensembl chr19:23,494,184...23,499,211
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:7614408 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igbp1 |
immunoglobulin binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21339737 |
|
NCBI chr X:65,582,832...65,605,078
Ensembl chr X:65,582,821...65,606,049
|
|
G |
Ikbkg |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17114358 |
|
NCBI chr X:152,216,485...152,241,476
Ensembl chr X:152,216,596...152,239,499
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14587096 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22369883 PMID:28212736 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:7614408 PMID:18298334 PMID:18625569 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il24 |
interleukin 24 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12830052 PMID:15713900 |
|
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26372664 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Iqsec1 |
IQ motif and Sec7 domain ArfGEF 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr 4:123,168,719...123,488,300
Ensembl chr 4:123,168,719...123,488,172
|
|
G |
Irf1 |
interferon regulatory factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
|
|
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
|
|
G |
Irf4 |
interferon regulatory factor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35915169 |
|
NCBI chr17:33,721,800...33,742,570
Ensembl chr17:33,721,811...33,740,070
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17804716 |
|
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20716630 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16289808 PMID:27935865 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Jund |
JunD proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
|
|
G |
Kdr |
kinase insert domain receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35917945 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:7614698 PMID:7750092 PMID:8508514 PMID:8597069 PMID:8761429 PMID:10223196 PMID:10545420 PMID:10874023 PMID:11641043 PMID:11745231 PMID:11884234 PMID:12376484 PMID:12725029 PMID:16247444 PMID:16271038 PMID:16289808 PMID:16410370 PMID:16823377 PMID:17233834 PMID:17290066 PMID:17325976 PMID:18062963 PMID:18758463 PMID:18927287 PMID:19336973 PMID:19424582 PMID:19555203 PMID:20101149 PMID:21519798 PMID:22028818 PMID:25851810 PMID:26390243 PMID:29247004 PMID:33380422 PMID:19966866 More...
|
RGD:11568678 |
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Lect2 |
leukocyte cell-derived chemotaxin 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:30453282 |
|
NCBI chr17:8,044,759...8,050,983
Ensembl chr17:8,044,759...8,050,983
|
|
G |
Lmntd1 |
lamin tail domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15064703 |
|
NCBI chr 4:178,354,302...178,588,483
Ensembl chr 4:178,354,137...178,588,477
|
|
G |
LOC120095955 |
mucin-12-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29054765 |
|
NCBI chr12:19,486,041...19,493,995
|
|
G |
Map2k3 |
mitogen activated protein kinase kinase 3 |
|
ISO |
|
RGD |
PMID:24233520 |
RGD:7495808 |
NCBI chr10:45,608,145...45,629,492
Ensembl chr10:45,607,163...45,629,492
|
|
G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21317887 |
|
NCBI chr12:2,591,312...2,600,534
Ensembl chr12:2,591,219...2,604,222
|
|
G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
|
|
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
|
|
G |
Map4k4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr 9:42,200,708...42,326,708
Ensembl chr 9:42,200,278...42,326,698
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11884234 PMID:12376484 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
ameliorates |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17468755 PMID:31969449 |
RGD:151665505 |
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11884234 PMID:12083368 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr20:40,685,315...40,691,012
Ensembl chr20:40,685,315...40,691,012
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19903766 PMID:27935865 |
|
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20934974 |
|
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
|
|
G |
Mir10a |
microRNA 10a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr10:81,283,171...81,283,280
Ensembl chr10:81,283,171...81,283,280
|
|
G |
Mir127 |
microRNA 127 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:128,546,215...128,546,311
Ensembl chr 6:128,546,215...128,546,311
|
|
G |
Mir136 |
microRNA 136 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:128,549,096...128,549,177
Ensembl chr 6:128,549,096...128,549,177
|
|
G |
Mir146a |
microRNA 146a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
|
|
G |
Mir154 |
microRNA 154 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:128,752,947...128,753,030
Ensembl chr 6:128,752,947...128,753,030
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 PMID:27692344 |
|
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
|
|
G |
Mir193a |
microRNA 193a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr10:64,672,343...64,672,454
Ensembl chr10:64,672,343...64,672,454
|
|
G |
Mir1b |
microRNA 1b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23761296 |
|
NCBI chr 3:167,487,117...167,487,201
Ensembl chr 3:167,487,117...167,487,201
|
|
G |
Mir21 |
microRNA 21 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27323401 |
|
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mir222 |
microRNA 222 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr X:3,428,904...3,429,006
Ensembl chr X:3,428,904...3,429,006
|
|
G |
Mir224 |
microRNA 224 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr X:150,065,088...150,065,169
Ensembl chr X:150,065,088...150,065,169
|
|
G |
Mir30a |
microRNA 30a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 9:25,737,600...25,737,670
Ensembl chr 9:25,737,600...25,737,670
|
|
G |
Mir31 |
microRNA 31 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20237410 |
|
NCBI chr 5:103,599,038...103,599,143
|
|
G |
Mir34b |
microRNA 34b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21339737 PMID:25105010 |
|
NCBI chr 8:51,410,244...51,410,327
Ensembl chr 8:51,410,244...51,410,327
|
|
G |
Mir34c |
microRNA 34c |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 8:51,409,726...51,409,802
Ensembl chr 8:51,409,726...51,409,802
|
|
G |
Mir370 |
microRNA 370 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:128,572,257...128,572,335
Ensembl chr 6:128,572,257...128,572,335
|
|
G |
Mir409 |
microRNA 409 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:128,757,780...128,757,856
Ensembl chr 6:128,757,779...128,757,858
|
|
G |
Mir410 |
microRNA 410 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:128,758,358...128,758,433
Ensembl chr 6:128,758,354...128,758,434
|
|
G |
Mir487b |
microRNA 487b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:128,741,485...128,741,566
Ensembl chr 6:128,741,485...128,741,566
|
|
G |
Mir494 |
microRNA 494 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:128,728,710...128,728,792
Ensembl chr 6:128,728,709...128,728,793
|
|
G |
Mir98 |
microRNA 98 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27270317 |
|
NCBI chr X:20,981,235...20,981,342
Ensembl chr X:20,981,235...20,981,342
|
|
G |
Mirlet7bhg |
Mirlet7b host gene |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26199339 |
|
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
no_association |
ISO |
DNA:insertion:promoter:g.-1607insG (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:23548910 PMID:19843588 |
RGD:7207056 |
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp10 |
matrix metallopeptidase 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22022614 |
|
NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:19596921 |
RGD:5129528 |
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
Pulmonary Sclerosing Hemangioma; mRNA, protein:increased expression:lung associated with lung disease; protein:decreased expression:pleural fluid |
RGD |
PMID:17914564 PMID:20216542 |
RGD:5130173, RGD:5129491 |
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12111688 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mpp1 |
MAGUK p55 scaffold protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17389614 |
|
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
treatment |
ISO |
|
RGD |
PMID:19966866 |
RGD:11568678 |
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Muc16 |
mucin 16, cell surface associated |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29552305 |
|
NCBI chr 8:16,164,531...16,323,126
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16289808 PMID:28191284 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myo18b |
myosin XVIIIb |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29054765 |
|
NCBI chr12:43,747,003...43,953,694
Ensembl chr12:43,747,010...43,953,695
|
|
G |
Nat1 |
N-acetyltransferase 1 |
susceptibility |
ISO |
DNA:polymorphism: : |
RGD |
PMID:9626964 |
RGD:5131866 |
NCBI chr16:22,218,217...22,238,516
Ensembl chr16:22,208,194...22,238,520
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31227482 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfya |
nuclear transcription factor Y subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16271038 |
|
NCBI chr 9:12,587,437...12,613,911
Ensembl chr 9:12,586,259...12,613,898
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12460898 PMID:22369883 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Notch2 |
notch receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17804716 |
|
NCBI chr 2:185,610,594...185,744,088
Ensembl chr 2:185,610,589...185,744,088
|
|
G |
Notch3 |
notch receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17804716 |
|
NCBI chr 7:11,132,984...11,184,025
Ensembl chr 7:11,133,706...11,184,025
|
|
G |
Nppa |
natriuretic peptide A |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:18717826 |
|
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
susceptibility |
ISO |
DNA:polymorphism: : 609C>T (human) DNA:SNP: :609C>T (human) DNA:polymorphism:cds: |
RGD |
PMID:15781212 PMID:12018106 PMID:18798003 |
RGD:5134987, RGD:10769350, RGD:5134963 |
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nrg1 |
neuregulin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28604730 |
|
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:17441966 PMID:19336973 |
|
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
|
|
G |
Pcna |
proliferating cell nuclear antigen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11884234 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pdcd1 |
programmed cell death 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34166680 |
|
NCBI chr 9:94,418,786...94,431,945
Ensembl chr 9:94,418,791...94,431,937
|
|
G |
Pdcd4 |
programmed cell death 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27323401 |
|
NCBI chr 1:252,921,342...252,944,278
Ensembl chr 1:252,921,392...252,944,275
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
|
ISO |
|
RGD |
PMID:17050049 |
RGD:2292176 |
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
|
|
G |
Pdlim4 |
PDZ and LIM domain 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr10:38,198,686...38,212,935
Ensembl chr10:38,198,689...38,212,938
|
|
G |
Pggt1b |
protein geranylgeranyltransferase type I subunit beta |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:22028818 |
|
NCBI chr18:38,952,147...38,995,656
Ensembl chr18:38,952,914...38,995,503
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16847462 |
RGD:2290476 |
NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032
|
|
G |
Plau |
plasminogen activator, urokinase |
severity |
ISO |
protein:increased expression:tumor, cytoplasm (human) |
RGD |
PMID:2054790 |
RGD:7241261 |
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Pon1 |
paraoxonase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16323636 |
|
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
|
|
G |
Ppbp |
pro-platelet basic protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr14:17,302,326...17,303,130
Ensembl chr14:17,302,326...17,303,130
|
|
G |
Ppp1r9b |
protein phosphatase 1, regulatory subunit 9B |
severity |
ISO |
protein:decreased expression:lung (human) |
RGD |
PMID:21598252 |
RGD:10043809 |
NCBI chr10:79,938,055...79,954,085
Ensembl chr10:79,938,066...79,954,083
|
|
G |
Ppp2r1b |
protein phosphatase 2 scaffold subunit A beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
|
|
NCBI chr 8:51,195,860...51,228,442
Ensembl chr 8:51,186,717...51,228,485
|
|
G |
Prdx1 |
peroxiredoxin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22537621 |
|
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
|
|
G |
Prdx6 |
peroxiredoxin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23692979 |
|
NCBI chr13:73,528,746...73,539,295
Ensembl chr13:73,528,210...73,539,355
|
|
G |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19946270 PMID:25640678 |
|
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17909629 PMID:27980214 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ptgis |
prostaglandin I2 synthase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11830527 |
|
NCBI chr 3:155,928,564...155,964,228
Ensembl chr 3:155,916,412...155,965,451
|
|
G |
Ptma |
prothymosin alpha |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:10822126 |
|
NCBI chr 9:87,176,251...87,180,333
Ensembl chr 9:87,176,230...87,180,333
|
|
G |
Pycard |
PYD and CARD domain containing |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16778195 |
|
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
|
|
G |
Rad52 |
RAD52 homolog, DNA repair protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26013599 |
|
NCBI chr 4:153,106,062...153,128,598
Ensembl chr 4:153,106,062...153,128,207
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11884234 |
|
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
|
|
G |
Ramp2 |
receptor activity modifying protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17671114 |
|
NCBI chr10:86,187,366...86,190,692
Ensembl chr10:86,188,812...86,231,829
|
|
G |
Rarb |
retinoic acid receptor, beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14656941 |
|
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
|
|
G |
Rassf1 |
Ras association domain family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18337602 PMID:12222680 PMID:17325427 |
RGD:2291977, RGD:2291979 |
NCBI chr 8:108,225,023...108,236,164
Ensembl chr 8:108,225,023...108,236,164
|
|
G |
Rchy1 |
ring finger and CHY zinc finger domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28191284 |
|
NCBI chr14:16,113,263...16,129,017
Ensembl chr14:16,113,224...16,129,167
|
|
G |
Riox2 |
ribosomal oxygenase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15897898 |
|
NCBI chr11:40,861,365...40,884,782
Ensembl chr11:40,860,774...40,884,574
|
|
G |
Rnaset2 |
ribonuclease T2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28604730 |
|
NCBI chr 1:52,576,344...52,603,151
Ensembl chr 1:52,585,929...52,603,147
|
|
G |
Robo1 |
roundabout guidance receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17671114 |
|
NCBI chr11:10,580,863...11,621,675
Ensembl chr11:10,580,908...11,620,203
|
|
G |
Rtel1 |
regulator of telomere elongation helicase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28604730 |
|
NCBI chr 3:168,427,247...168,465,349
Ensembl chr 3:168,419,579...168,465,348
|
|
G |
Runx3 |
RUNX family transcription factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr 5:147,360,587...147,419,161
Ensembl chr 5:147,360,994...147,419,156
|
|
G |
Scgb3a2 |
secretoglobin, family 3A, member 2 |
|
ISO |
|
RGD |
PMID:20466451 PMID:19418968 |
RGD:5147390, RGD:5147392 |
NCBI chr18:35,932,840...35,935,762
Ensembl chr18:35,932,840...35,935,762
|
|
G |
Secisbp2l |
SECIS binding protein 2-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28604730 |
|
NCBI chr 3:112,989,613...113,036,060
Ensembl chr 3:112,991,908...113,035,884
|
|
G |
Selenbp1 |
selenium binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14991897 |
|
NCBI chr 2:182,494,004...182,504,594
Ensembl chr 2:182,493,978...182,504,594
|
|
G |
Selenop |
selenoprotein P |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19058871 |
|
NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852
|
|
G |
Serpina1 |
serpin family A member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17902193 |
|
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
|
|
G |
Serping1 |
serpin family G member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
|
|
G |
Sftpb |
surfactant protein B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16570259 |
|
NCBI chr 4:104,359,303...104,368,439
Ensembl chr 4:104,359,396...104,368,436
|
|
G |
Sftpd |
surfactant protein D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14522914 PMID:15136449 |
|
NCBI chr16:17,046,491...17,058,968
Ensembl chr16:17,046,483...17,059,927
|
|
G |
Sidt2 |
SID1 transmembrane family, member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr 8:46,232,379...46,248,913
Ensembl chr 8:46,232,383...46,248,700
|
|
G |
Slc22a18 |
solute carrier family 22, member 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
|
|
NCBI chr 1:198,670,626...198,694,977
Ensembl chr 1:198,671,731...198,694,975
|
|
G |
Slc3a2 |
solute carrier family 3 member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26621329 |
|
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26621329 |
|
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
|
|
G |
Slco1b2 |
solute carrier organic anion transporter family member 1B2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22326869 PMID:25625007 |
|
NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981
|
|
G |
Smarcc1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr 8:110,111,097...110,214,734
Ensembl chr 8:110,111,122...110,214,720
|
|
G |
Smc2 |
structural maintenance of chromosomes 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr 5:66,806,882...66,853,478
Ensembl chr 5:66,807,011...66,853,242
|
|
G |
Snd1 |
staphylococcal nuclease and tudor domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25940438 |
|
NCBI chr 4:57,095,205...57,494,501
Ensembl chr 4:57,095,208...57,530,843
|
|
G |
Sox2 |
SRY-box transcription factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19801978 |
|
NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
|
|
G |
Sox30 |
SRY-box transcription factor 30 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25435374 |
|
NCBI chr10:30,417,499...30,446,441
Ensembl chr10:30,418,473...30,446,453
|
|
G |
Sox9 |
SRY-box transcription factor 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 PMID:22481206 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Spry2 |
sprouty RTK signaling antagonist 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15136453 |
|
NCBI chr15:82,692,291...82,697,408
Ensembl chr15:82,692,143...82,698,009
|
|
G |
Srsf1 |
serine and arginine rich splicing factor 1 |
|
ISO |
protein:increased expression:lung (mouse) |
RGD |
PMID:15390079 |
RGD:11038777 |
NCBI chr10:72,838,926...72,859,066
Ensembl chr10:72,839,274...72,845,336
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:38101582 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stat5a |
signal transducer and activator of transcription 5A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr10:85,785,537...85,809,869
Ensembl chr10:85,785,537...85,809,866
|
|
G |
Stim1 |
stromal interaction molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27863410 |
|
NCBI chr 1:156,656,246...156,818,777
Ensembl chr 1:156,656,013...156,818,363
|
|
G |
Stk11 |
serine/threonine kinase 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17676035 |
|
NCBI chr 7:9,574,553...9,591,315
Ensembl chr 7:9,575,269...9,591,315
|
|
G |
Stn1 |
STN1 subunit of CST complex |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28604730 |
|
NCBI chr 1:246,391,311...246,429,844
Ensembl chr 1:246,395,613...246,429,531
|
|
G |
Tep1 |
telomerase associated protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11323394 |
|
NCBI chr15:24,045,876...24,093,526
Ensembl chr15:24,045,878...24,093,526
|
|
G |
Tert |
telomerase reverse transcriptase |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:11323394 PMID:19151717 PMID:23433592 PMID:19903903 |
RGD:11038656 |
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
|
|
G |
Tfrc |
transferrin receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16904380 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:11074608 PMID:11641043 PMID:17418594 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfbr2 |
transforming growth factor, beta receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11074608 |
|
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19925653 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tlr9 |
toll-like receptor 9 |
|
ISO |
mRNA, protein:increased expression:tumor (human) |
RGD |
PMID:18763053 |
RGD:5130705 |
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
|
|
G |
Tmem45a |
transmembrane protein 45A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27935865 |
|
NCBI chr11:43,713,309...43,799,526
Ensembl chr11:43,713,782...43,799,526
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14587096 PMID:22369883 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO IMP |
CTD Direct Evidence: marker/mechanism|therapeutic DNA:transitional mutations:exons: |
CTD RGD |
PMID:8049841 PMID:11798837 PMID:16247444 PMID:16410370 PMID:17325666 PMID:20727180 PMID:26192916 PMID:26390243 PMID:15118671 PMID:10564948 More...
|
RGD:1331525, RGD:11075092 |
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp63 |
tumor protein p63 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20871597 PMID:21725308 |
|
NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
|
|
G |
Tp73 |
tumor protein p73 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28212736 |
|
NCBI chr 5:164,621,377...164,703,958
Ensembl chr 5:164,621,377...164,681,128
|
|
G |
Tsc1 |
TSC complex subunit 1 |
|
ISO |
|
RGD |
PMID:19966866 |
RGD:11568678 |
NCBI chr 3:11,969,547...12,018,591
Ensembl chr 3:11,979,729...12,015,674
|
|
G |
Tsc2 |
TSC complex subunit 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30008631 |
|
NCBI chr10:13,621,135...13,655,773
Ensembl chr10:13,621,136...13,655,951
|
|
G |
Tshr |
thyroid stimulating hormone receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9062474 |
|
NCBI chr 6:110,341,585...110,475,297
Ensembl chr 6:110,341,581...110,474,538
|
|
G |
Ttr |
transthyretin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17902193 PMID:19180532 |
|
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
|
|
G |
Tyms |
thymidylate synthetase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18281538 PMID:19020767 |
|
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
|
|
G |
Tyrp1 |
tyrosinase-related protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr 5:95,280,982...95,299,516
Ensembl chr 5:95,280,982...95,299,516
|
|
G |
Ugt2b1 |
UDP glucuronosyltransferase 2 family, polypeptide B1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17416778 |
|
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
|
|
G |
Usp18 |
ubiquitin specific peptidase 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27980214 |
|
NCBI chr 4:154,471,634...154,499,154
Ensembl chr 4:154,471,592...154,499,144
|
|
G |
Vhl |
von Hippel-Lindau tumor suppressor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16061637 |
|
NCBI chr 4:146,772,483...146,779,376
Ensembl chr 4:146,772,468...146,779,377
|
|
G |
Wnt5a |
Wnt family member 5A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23349696 |
|
NCBI chr16:3,697,032...3,718,230
Ensembl chr16:3,697,032...3,718,234
|
|
G |
Wt1 |
WT1 transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14961577 |
|
NCBI chr 3:91,566,540...91,613,653
Ensembl chr 3:91,567,001...91,613,643
|
|
G |
Xpc |
XPC complex subunit, DNA damage recognition and repair factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17325666 PMID:24084170 |
|
NCBI chr 4:123,993,670...124,020,922
Ensembl chr 4:123,993,666...124,021,010
|
|
|
G |
Ttr |
transthyretin |
|
ISO |
protein:increased expression:lung (human) |
RGD |
PMID:26943652 |
RGD:151665207 |
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
|
|
|
G |
Adam28 |
ADAM metallopeptidase domain 28 |
|
ISO |
associated with lung adenocarcinoma ;mRNA:increased expression:lung |
RGD |
PMID:20544843 |
RGD:153298907 |
NCBI chr15:43,774,463...43,840,726
Ensembl chr15:42,944,467...43,840,672
|
|
G |
Kif5a |
kinesin family member 5A |
susceptibility |
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:21231887 |
RGD:12793066 |
NCBI chr 7:63,051,894...63,089,024
Ensembl chr 7:63,049,424...63,092,858
|
|
G |
Rarb |
retinoic acid receptor, beta |
|
ISO |
DNA:hypomethylation:lung |
RGD |
PMID:28722770 |
RGD:13503322 |
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
|
|
|
G |
Alx4 |
ALX homeobox 4 |
ameliorates |
ISO |
|
RGD |
PMID:24037716 |
RGD:153344522 |
NCBI chr 3:79,611,682...79,648,260
Ensembl chr 3:79,611,719...79,648,260
|
|
G |
Ccnd1 |
cyclin D1 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:14674039 |
RGD:13434930 |
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
disease_progression |
ISO |
|
RGD |
PMID:19484794 |
RGD:4140940 |
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO IMP |
DNA:snp:cds:p.T790M (human) DNA:mutations:exons: protein:increased expression:tumor (human) |
RGD |
PMID:15737014 PMID:26059825 PMID:21419590 |
RGD:5131465, RGD:11075076, RGD:5131630 |
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egr1 |
early growth response 1 |
|
ISO |
mRNA:decreased expression:tumor (human) |
RGD |
PMID:11948124 |
RGD:5131942 |
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
DNA:hypermethylation:promoter (human) |
RGD |
PMID:19484794 |
RGD:4140940 |
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
IMP |
DNA:mutations:cds: |
RGD |
PMID:26059825 |
RGD:11075076 |
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Mir130a |
microRNA 130a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25926378 |
|
NCBI chr 3:69,822,542...69,822,629
Ensembl chr 3:69,822,542...69,822,629
|
|
G |
Mir144 |
microRNA 144 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25926378 |
|
NCBI chr10:62,961,348...62,961,430
Ensembl chr10:62,961,348...62,961,430
|
|
G |
Mir19a |
microRNA 19a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25926378 |
|
NCBI chr15:92,180,912...92,180,993
Ensembl chr15:92,180,912...92,180,993
|
|
G |
Mir345 |
microRNA 345 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25926378 |
|
NCBI chr 6:127,754,027...127,754,122
Ensembl chr 6:127,754,027...127,754,122
|
|
G |
Mir497 |
microRNA 497 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25926378 |
|
NCBI chr10:54,951,514...54,951,582
Ensembl chr10:54,951,505...54,951,584
|
|
G |
Tp53 |
tumor protein p53 |
|
IMP |
DNA:mutations:exons: |
RGD |
PMID:26059825 |
RGD:11075076 |
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
mRNA:decreased expression:bronchus, epithelial cell |
RGD |
PMID:10749130 |
RGD:4142527 |
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
protein:increased secretion:lung (human) |
RGD |
PMID:18764914 |
RGD:4145523 |
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:8030748 |
RGD:4143231 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
protein:increased expression, alternative forms:lung |
RGD |
PMID:8030748 |
RGD:4143231 |
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
|
G |
Sdha |
succinate dehydrogenase complex flavoprotein subunit A |
|
ISO |
ClinVar Annotator: match by term: Carney triad | ClinVar Annotator: match by term: GASTRIC LEIOMYOSARCOMA, PULMONARY CHONDROMA, AND EXTRAADRENAL PARAGANGLIOMA |
ClinVar |
PMID:20484225 PMID:21505157 PMID:21752896 PMID:22955521 PMID:22974104 PMID:23174939 PMID:23252569 PMID:23612575 PMID:23666964 PMID:23730622 PMID:24781757 PMID:25494863 PMID:25525159 PMID:25741868 PMID:26113600 PMID:26173966 PMID:26259135 PMID:26269449 PMID:26467025 PMID:26490314 PMID:26689913 PMID:27895137 PMID:28384794 PMID:28492532 PMID:28500238 PMID:28819017 PMID:29177515 PMID:29625052 PMID:29872718 PMID:29978154 PMID:29978187 PMID:30068732 PMID:30877234 PMID:31368675 PMID:31589614 PMID:31827275 PMID:32581362 PMID:32782288 PMID:33077847 PMID:33372952 PMID:33674644 PMID:33960148 PMID:35059314 PMID:35441217 More...
|
|
NCBI chr 1:28,935,965...28,960,936
Ensembl chr 1:28,940,164...28,961,535
|
|
G |
Sdhb |
succinate dehydrogenase complex iron sulfur subunit B |
|
ISO |
ClinVar Annotator: match by term: GASTRIC LEIOMYOSARCOMA, PULMONARY CHONDROMA, AND EXTRAADRENAL PARAGANGLIOMA |
ClinVar |
PMID:15987702 PMID:16288654 PMID:16317055 PMID:16912137 PMID:16916404 PMID:17200167 PMID:17667967 PMID:17884808 PMID:19001511 PMID:19215943 PMID:19802898 PMID:21820839 PMID:23282968 PMID:24033266 PMID:24623741 PMID:25371406 PMID:25683602 PMID:25741868 PMID:25972245 PMID:26173966 PMID:26467025 PMID:26916530 PMID:28070496 PMID:28152038 PMID:28349240 PMID:28374168 PMID:28492532 PMID:28738844 PMID:28873162 PMID:29386252 PMID:30050099 PMID:30201732 PMID:31308404 More...
|
|
NCBI chr 5:153,264,906...153,285,570
Ensembl chr 5:153,264,899...153,314,293
|
|
G |
Sdhc |
succinate dehydrogenase complex subunit C |
|
ISO |
ClinVar Annotator: match by term: Carney triad | ClinVar Annotator: match by term: GASTRIC LEIOMYOSARCOMA, PULMONARY CHONDROMA, AND EXTRAADRENAL PARAGANGLIOMA |
ClinVar |
PMID:9536098 PMID:12658451 PMID:17576681 PMID:17667967 PMID:17804857 PMID:19351833 PMID:21173220 PMID:21822798 PMID:24402737 PMID:25787132 PMID:26173966 PMID:28492532 More...
|
|
NCBI chr13:83,544,652...83,565,560
Ensembl chr13:83,544,652...83,566,253
|
|
|
G |
Asb2 |
ankyrin repeat and SOCS box-containing 2 |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
ClinVar |
PMID:26545620 PMID:26555935 PMID:28492532 |
|
NCBI chr 6:122,474,754...122,511,014
Ensembl chr 6:122,474,756...122,510,854
|
|
G |
Btbd7 |
BTB domain containing 7 |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
ClinVar |
PMID:26545620 PMID:26555935 PMID:28492532 |
|
NCBI chr 6:121,920,365...122,010,114
Ensembl chr 6:121,923,023...121,972,405
|
|
G |
Cox8c |
cytochrome c oxidase subunit 8C |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
ClinVar |
PMID:26545620 PMID:26555935 PMID:28492532 |
|
NCBI chr 6:122,028,566...122,029,889
Ensembl chr 6:122,028,566...122,029,889
|
|
G |
Ddx24 |
DEAD-box helicase 24 |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
ClinVar |
PMID:26545620 PMID:26555935 PMID:28492532 |
|
NCBI chr 6:122,564,767...122,582,032
Ensembl chr 6:122,564,767...122,581,927
|
|
G |
Dicer1 |
dicer 1 ribonuclease III |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
OMIM ClinVar |
PMID:9295070 PMID:9345104 PMID:9536098 PMID:15242644 PMID:15987463 PMID:16095561 PMID:16199547 PMID:17576681 PMID:17920623 PMID:17923214 PMID:18453628 PMID:18570301 PMID:19556464 PMID:21036787 PMID:21205968 PMID:21266384 PMID:21346072 PMID:21501861 PMID:21882293 PMID:22157934 PMID:22180160 PMID:22187960 PMID:22546613 PMID:22717647 PMID:23068969 PMID:23132766 PMID:23418872 PMID:23547758 PMID:23620094 PMID:23622242 PMID:23728841 PMID:23868280 PMID:24033266 PMID:24065110 PMID:24136150 PMID:24151152 PMID:24481001 PMID:24513630 PMID:24617712 PMID:24628552 PMID:24675358 PMID:24676357 PMID:24708902 PMID:24728327 PMID:24823459 PMID:24839956 PMID:24909177 PMID:24909261 PMID:25022261 PMID:25118636 PMID:25176334 PMID:25190313 PMID:25231023 PMID:25348012 PMID:25356068 PMID:25451712 PMID:25525159 PMID:25526195 PMID:25640679 PMID:25670082 PMID:25670083 PMID:25741868 PMID:25803323 PMID:25836323 PMID:25998712 PMID:26033159 PMID:26033501 PMID:26241669 PMID:26289771 PMID:26408257 PMID:26428316 PMID:26461232 PMID:26467025 PMID:26475046 PMID:26517685 PMID:26526666 PMID:26545620 PMID:26555935 PMID:26556299 PMID:26566882 PMID:26577641 PMID:26580448 PMID:26592504 PMID:26639818 PMID:26666178 PMID:26822237 PMID:26833330 PMID:26841698 PMID:26886166 PMID:26893459 PMID:26925222 PMID:26928971 PMID:26983701 PMID:27036314 PMID:27050224 PMID:27126690 PMID:27459524 PMID:27494611 PMID:27664536 PMID:27697588 PMID:27784193 PMID:27819237 PMID:27830405 PMID:27896549 PMID:27930734 PMID:28007021 PMID:28012864 PMID:28097783 PMID:28177962 PMID:28202063 PMID:28222777 PMID:28323992 PMID:28459098 PMID:28492532 PMID:28502826 PMID:28524158 PMID:28562508 PMID:28624956 PMID:28654427 PMID:28688118 PMID:28748527 PMID:28766837 PMID:28825729 PMID:28834809 PMID:28862265 PMID:28873162 PMID:28960912 PMID:29037807 PMID:29187512 PMID:29276006 PMID:29315962 PMID:29351919 PMID:29395683 PMID:29399970 PMID:29459759 PMID:29469200 PMID:29474644 PMID:29538609 PMID:29625052 PMID:29633305 PMID:29641532 PMID:29660837 PMID:29706542 PMID:29708584 PMID:29726952 PMID:29753010 PMID:29762508 PMID:29881993 PMID:29883781 PMID:29938629 PMID:29943907 PMID:29945567 PMID:30014022 PMID:30072170 PMID:30093976 PMID:30097050 PMID:30178239 PMID:30260442 PMID:30266945 PMID:30339877 PMID:30446821 PMID:30585947 PMID:30597651 PMID:30649606 PMID:30665929 PMID:30672147 PMID:30989777 PMID:31067372 PMID:31278746 PMID:31285663 PMID:31296931 PMID:31300551 PMID:31342592 PMID:31417090 PMID:31820118 PMID:31838154 PMID:31883967 PMID:31900434 PMID:31911633 PMID:32291395 PMID:32371905 PMID:32692439 PMID:32714280 PMID:32832834 PMID:32973888 PMID:33158809 PMID:33208384 PMID:33372952 PMID:33460435 PMID:33484847 PMID:33630087 PMID:33718253 PMID:33729574 PMID:33767345 PMID:33782093 PMID:34291157 PMID:34313605 PMID:34761719 PMID:34913555 PMID:35194848 PMID:37248399 PMID:37333613 More...
|
|
NCBI chr 6:123,627,529...123,692,278
Ensembl chr 6:123,631,250...123,693,965
|
|
G |
Fam181a |
family with sequence similarity 181, member A |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
ClinVar |
PMID:26545620 PMID:26555935 PMID:28492532 |
|
NCBI chr 6:122,465,373...122,471,397
Ensembl chr 6:122,465,391...122,471,397
|
|
G |
Gsc |
goosecoid homeobox |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
ClinVar |
PMID:26545620 PMID:26555935 PMID:28492532 |
|
NCBI chr 6:123,388,072...123,390,111
Ensembl chr 6:123,388,072...123,390,111
|
|
G |
Ifi27 |
interferon, alpha-inducible protein 27 |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
ClinVar |
PMID:26545620 PMID:26555935 PMID:28492532 |
|
NCBI chr 6:122,590,461...122,596,996
Ensembl chr 6:122,590,472...122,779,294
|
|
G |
Ifi27l2a |
interferon, alpha-inducible protein 27 like 2A |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
ClinVar |
PMID:26545620 PMID:26555935 PMID:28492532 |
|
NCBI chr 6:122,598,872...122,600,358
Ensembl chr 6:122,598,872...122,600,360
|
|
G |
Otub2 |
OTU deubiquitinase, ubiquitin aldehyde binding 2 |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
ClinVar |
PMID:26545620 PMID:26555935 PMID:28492532 |
|
NCBI chr 6:122,545,067...122,563,657
Ensembl chr 6:122,545,061...122,563,644
|
|
G |
Ppp4r4 |
protein phosphatase 4, regulatory subunit 4 |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
ClinVar |
PMID:26545620 PMID:26555935 PMID:28492532 |
|
NCBI chr 6:122,663,172...122,753,988
Ensembl chr 6:122,663,344...122,753,384
|
|
G |
Prima1 |
proline rich membrane anchor 1 |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
ClinVar |
PMID:26545620 PMID:26555935 PMID:28492532 |
|
NCBI chr 6:122,338,365...122,390,955
Ensembl chr 6:122,338,370...122,389,921
|
|
G |
Serpina1 |
serpin family A member 1 |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
ClinVar |
PMID:26545620 PMID:26555935 PMID:28492532 |
|
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
|
|
G |
Serpina10 |
serpin family A member 10 |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
ClinVar |
PMID:26545620 PMID:26555935 PMID:28492532 |
|
NCBI chr 6:122,756,106...122,764,544
Ensembl chr 6:122,756,108...122,764,544
|
|
G |
Serpina11 |
serpin family A member 11 |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
ClinVar |
PMID:26545620 PMID:26555935 PMID:28492532 |
|
NCBI chr 6:122,903,246...122,912,695
Ensembl chr 6:122,903,250...122,912,670
|
|
G |
Serpina12 |
serpin family A member 12 |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
ClinVar |
PMID:26545620 PMID:26555935 PMID:28492532 |
|
NCBI chr 6:122,952,552...122,967,271
Ensembl chr 6:122,952,552...122,967,271
|
|
G |
Serpina1f |
serpin family A member 1F |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
ClinVar |
PMID:26545620 PMID:26555935 PMID:28492532 |
|
NCBI chr 6:122,820,752...122,827,112
Ensembl chr 6:122,820,907...122,827,112
|
|
G |
Serpina3n |
serpin family A member 3N |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
ClinVar |
PMID:26545620 PMID:26555935 PMID:28492532 |
|
NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433
|
|
G |
Serpina4 |
serpin family A member 4 |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
ClinVar |
PMID:26545620 PMID:26555935 PMID:28492532 |
|
NCBI chr 6:122,999,970...123,009,083
Ensembl chr 6:122,999,900...123,009,082
|
|
G |
Serpina5 |
serpin family A member 5 |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
ClinVar |
PMID:26545620 PMID:26555935 PMID:28492532 |
|
NCBI chr 6:123,009,224...123,028,412
Ensembl chr 6:123,023,306...123,028,407
|
|
G |
Serpina6 |
serpin family A member 6 |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
ClinVar |
PMID:26545620 PMID:26555935 PMID:28492532 |
|
NCBI chr 6:122,780,040...122,790,274
Ensembl chr 6:122,780,043...122,790,349
|
|
G |
Serpina9 |
serpin family A member 9 |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
ClinVar |
PMID:26545620 PMID:26555935 PMID:28492532 |
|
NCBI chr 6:122,918,819...122,936,000
Ensembl chr 6:122,918,880...122,936,000
|
|
G |
Ubr7 |
ubiquitin protein ligase E3 component n-recognin 7 |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
ClinVar |
PMID:26545620 PMID:26555935 PMID:28492532 |
|
NCBI chr 6:121,898,613...121,918,480
Ensembl chr 6:121,898,623...121,918,477
|
|
G |
Unc79 |
unc-79 homolog, NALCN channel complex subunit |
|
ISO |
ClinVar Annotator: match by term: DICER1 syndrome |
ClinVar |
PMID:26545620 PMID:26555935 PMID:28492532 |
|
NCBI chr 6:122,082,369...122,327,641
Ensembl chr 6:122,080,308...122,327,591
|
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
disease_progression |
ISO |
|
RGD |
PMID:18440724 |
RGD:151361285 |
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
|
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abce1 |
ATP binding cassette subfamily E member 1 |
severity |
ISO |
mRNA, protein:increased expression:lung (human) |
RGD |
PMID:18788636 |
RGD:11046260 |
NCBI chr19:28,205,566...28,230,489
Ensembl chr19:28,205,555...28,230,489
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
|
|
G |
Adam19 |
ADAM metallopeptidase domain 19 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr10:30,491,362...30,583,115
Ensembl chr10:30,491,405...30,583,105
|
|
G |
Adam28 |
ADAM metallopeptidase domain 28 |
exacerbates disease_progression treatment |
ISO |
protein:increased expression:lung |
RGD |
PMID:29882245 PMID:26800504 PMID:30190423 PMID:20112342 |
RGD:153297792, RGD:11531771, RGD:153297795, RGD:153297794 |
NCBI chr15:43,774,463...43,840,726
Ensembl chr15:42,944,467...43,840,672
|
|
G |
Adamtsl3 |
ADAMTS-like 3 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 1:136,288,793...136,596,986
Ensembl chr 1:136,288,793...136,596,986
|
|
G |
Adgrg6 |
adhesion G protein-coupled receptor G6 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 1:8,812,889...8,954,239
Ensembl chr 1:8,812,904...8,954,123
|
|
G |
Ahcy |
adenosylhomocysteinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12597446 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
disease_progression |
ISO |
|
RGD |
PMID:30727821 |
RGD:27226687 |
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung |
ClinVar |
PMID:17611497 PMID:18256540 PMID:18392055 PMID:18504432 PMID:18611285 PMID:18954143 PMID:19418217 PMID:19487299 PMID:19853286 PMID:20233444 PMID:20453058 PMID:21464312 PMID:21512767 PMID:21793738 PMID:22538770 PMID:22610119 PMID:22722201 PMID:22722839 PMID:22980975 PMID:23237847 PMID:23348505 PMID:23700467 PMID:23728071 PMID:23934607 PMID:24190505 PMID:24657128 PMID:25157968 PMID:25741868 PMID:26619011 PMID:28492532 More...
|
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh18a1 |
aldehyde dehydrogenase 18 family, member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:239,375,657...239,407,956
Ensembl chr 1:239,375,669...239,407,890
|
|
G |
Aldoa |
aldolase, fructose-bisphosphate A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
|
|
G |
Alk |
ALK receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Lung adenocarcinoma |
CTD ClinVar |
PMID:18923525 PMID:20979469 PMID:20979473 PMID:21030459 PMID:21575866 PMID:21791641 PMID:21823889 PMID:21838707 PMID:21948233 PMID:22071784 PMID:22072639 PMID:22135231 PMID:22153831 PMID:22235099 PMID:22277784 PMID:22743652 PMID:22980554 PMID:22999080 PMID:23344087 PMID:24327273 PMID:24670165 PMID:25741868 PMID:26619011 PMID:27993330 More...
|
|
NCBI chr 6:22,879,653...23,599,636
Ensembl chr 6:22,880,625...23,598,034
|
|
G |
Alox12b |
arachidonate 12-lipoxygenase, 12R type |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30258081 |
|
NCBI chr10:53,863,060...53,874,938
Ensembl chr10:53,863,060...53,874,938
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30258081 |
|
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Alx1 |
ALX homeobox 1 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 7:38,157,626...38,177,220
Ensembl chr 7:38,147,117...38,177,220
|
|
G |
Alx4 |
ALX homeobox 4 |
disease_progression |
ISO |
|
RGD |
PMID:18978557 |
RGD:153350135 |
NCBI chr 3:79,611,682...79,648,260
Ensembl chr 3:79,611,719...79,648,260
|
|
G |
Anapc2 |
anaphase promoting complex subunit 2 |
severity |
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:12036940 |
RGD:14696682 |
NCBI chr 3:8,086,434...8,098,182
Ensembl chr 3:8,086,462...8,098,178
|
|
G |
Anp32a |
acidic nuclear phosphoprotein 32 family member A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 8:62,829,099...62,865,443
Ensembl chr 8:62,827,456...62,865,443
|
|
G |
Anxa1 |
annexin A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa5 |
annexin A5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:1316610 PMID:1338764 PMID:2281069 PMID:8187091 PMID:8381579 PMID:9824584 PMID:10646887 PMID:15311282 PMID:16134147 PMID:17293347 PMID:18433509 PMID:18948947 PMID:20223039 PMID:20685668 PMID:20924072 PMID:21901162 PMID:22135120 PMID:22987206 PMID:23700467 PMID:25157968 PMID:25741868 PMID:27081525 PMID:27993330 PMID:28492532 More...
|
|
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Apoc3 |
apolipoprotein C3 |
|
ISO |
protein:altered glycosylation:: |
RGD |
PMID:19322776 |
RGD:153344619 |
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
|
|
G |
Aqp4 |
aquaporin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
|
|
G |
Araf |
A-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:24569458 PMID:26619011 |
|
NCBI chr X:1,227,392...1,292,356
Ensembl chr X:1,227,392...1,239,073
|
|
G |
Arg1 |
arginase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arhgap35 |
Rho GTPase activating protein 35 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27158780 |
|
NCBI chr 1:77,202,436...77,319,298
Ensembl chr 1:77,202,436...77,319,298
|
|
G |
Arhgap44 |
Rho GTPase activating protein 44 |
|
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:28527113 |
RGD:401901290 |
NCBI chr10:49,655,583...49,822,876
Ensembl chr10:49,655,584...49,824,297
|
|
G |
Atp5pd |
ATP synthase peripheral stalk subunit d |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr10:100,657,700...100,662,960
Ensembl chr10:100,657,708...100,663,479
|
|
G |
Atrx |
ATRX, chromatin remodeler |
disease_progression |
ISO |
|
RGD |
PMID:31374064 |
RGD:127285382 |
NCBI chr X:70,850,981...70,997,330
Ensembl chr X:70,850,981...70,997,330
|
|
G |
Axin2 |
axin 2 |
susceptibility disease_progression |
ISO |
DNA:SNP:cds:p.P50S(human) DNA:SNPs::1712 +19 G>A,148 C>T(human) |
RGD |
PMID:16820935 PMID:30346805 |
RGD:151356657, RGD:151356655 |
NCBI chr10:93,893,830...93,927,042
Ensembl chr10:93,899,245...93,926,231
|
|
G |
Azgp1 |
alpha-2-glycoprotein 1, zinc-binding |
|
ISO |
mRNA,protein:increased expression:lung |
RGD |
PMID:17724461 |
RGD:153350134 |
NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091
|
|
G |
B2m |
beta-2 microglobulin |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung |
ClinVar |
PMID:26619011 |
|
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231345 |
|
NCBI chr16:6,446,709...6,455,535
Ensembl chr16:6,446,709...6,455,535
|
|
G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
|
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:18223678 |
RGD:151665316 |
NCBI chr 4:178,834,264...178,838,618
Ensembl chr 4:178,834,271...178,838,468
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
exacerbates |
ISO |
mRNA:increased expression:B cell (human) |
RGD |
PMID:33098370 |
RGD:153323293 |
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
ameliorates disease_progression |
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
CTD ClinVar |
PMID:12068308 PMID:12198537 PMID:12447372 PMID:12460918 PMID:12460919 PMID:12619120 PMID:12644542 PMID:12670889 PMID:12794760 PMID:12960123 PMID:14513361 PMID:14602780 PMID:14612909 PMID:14679157 PMID:14688025 PMID:15001635 PMID:15035987 PMID:15126572 PMID:15181070 PMID:15342696 PMID:15356022 PMID:15386408 PMID:15687339 PMID:15998781 PMID:16015629 PMID:16174717 PMID:16187918 PMID:16439621 PMID:16474404 PMID:16772349 PMID:16825433 PMID:17096326 PMID:17119447 PMID:17311103 PMID:17374713 PMID:17488796 PMID:17603483 PMID:17785355 PMID:18039235 PMID:18042262 PMID:18186519 PMID:18368129 PMID:18398503 PMID:18413255 PMID:18794803 PMID:19001320 PMID:19010912 PMID:19018267 PMID:19206169 PMID:19238210 PMID:19376813 PMID:19383316 PMID:19404918 PMID:19537845 PMID:19561230 PMID:19571295 PMID:19913317 PMID:20008640 PMID:20350999 PMID:20413299 PMID:20619739 PMID:20630094 PMID:20818844 PMID:20823850 PMID:20857202 PMID:21062266 PMID:21107320 PMID:21107323 PMID:21129611 PMID:21156289 PMID:21163703 PMID:21426297 PMID:21483012 PMID:21502544 PMID:21639808 PMID:21641636 PMID:21683865 PMID:21784453 PMID:21975775 PMID:22038996 PMID:22039425 PMID:22048237 PMID:22113612 PMID:22135231 PMID:22180495 PMID:22281684 PMID:22310681 PMID:22351686 PMID:22356324 PMID:22389471 PMID:22448344 PMID:22495831 PMID:22536370 PMID:22586120 PMID:22608338 PMID:22649091 PMID:22663011 PMID:22735384 PMID:22743296 PMID:22773810 PMID:22798288 PMID:22805292 PMID:22876591 PMID:22972589 PMID:22997239 PMID:23020132 PMID:23031422 PMID:23251002 PMID:23273605 PMID:23302800 PMID:23325582 PMID:23352452 PMID:23470635 PMID:23524406 PMID:23549875 PMID:23614898 PMID:23685455 PMID:23715574 PMID:23812671 PMID:23833300 PMID:23845441 PMID:23918947 PMID:24033266 PMID:24107445 PMID:24112392 PMID:24163374 PMID:24303953 PMID:24388723 PMID:24446311 PMID:24451042 PMID:24508103 PMID:24512911 PMID:24576830 PMID:24583796 PMID:24586605 PMID:24594804 PMID:24670642 PMID:24717435 PMID:24920063 PMID:25024077 PMID:25037139 PMID:25079330 PMID:25157968 PMID:25265492 PMID:25265494 PMID:25370471 PMID:25399551 PMID:25463315 PMID:25741868 PMID:25950823 PMID:25989278 PMID:26463840 PMID:26619011 PMID:26678033 PMID:27236105 PMID:27276561 PMID:27404270 PMID:27480103 PMID:28492532 PMID:28832562 PMID:28854169 PMID:28891408 PMID:29453417 PMID:29595366 PMID:29907801 PMID:29925953 PMID:31277584 PMID:31336229 PMID:31779674 PMID:31891627 PMID:33040082 PMID:34476331 More...
|
|
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
|
|
G |
Btk |
Bruton tyrosine kinase |
exacerbates susceptibility |
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:31803536 PMID:32351880 |
RGD:151347849, RGD:151347848 |
NCBI chr X:97,722,796...97,762,315
Ensembl chr X:97,722,802...97,761,853
|
|
G |
Bzw2 |
basic leucine zipper and W2 domains 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 6:52,828,069...52,888,599
Ensembl chr 6:52,827,661...52,888,628
|
|
G |
Cadm1 |
cell adhesion molecule 1 |
|
IEP |
DNA, mRNA:hypermethylation, decreased expression:promoter:liver |
RGD |
PMID:16814249 |
RGD:2289096 |
NCBI chr 8:47,847,836...48,178,703
Ensembl chr 8:47,847,325...48,182,833
|
|
G |
Calr |
calreticulin |
treatment |
ISO |
human cells and recombinant gene in a mouse model |
RGD |
PMID:18245558 |
RGD:150521698 |
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
|
|
G |
Capg |
capping actin protein, gelsolin like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856
|
|
G |
Cbx5 |
chromobox 5 |
disease_progression |
ISO |
mRNA,protein:increased expression:lung: |
RGD |
PMID:22900142 |
RGD:9586743 |
NCBI chr 7:134,333,165...134,376,102
Ensembl chr 7:134,331,335...134,375,022
|
|
G |
Cbx7 |
chromobox 7 |
|
ISO |
mRNA,DNA:decreased expression, loss of heterozygosity:lung: |
RGD |
PMID:22214847 |
RGD:9587356 |
NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973
|
|
G |
Ccnd1 |
cyclin D1 |
disease_progression treatment |
ISO |
|
RGD |
PMID:26681199 PMID:19355812 |
RGD:11536846, RGD:13434927 |
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
disease_progression |
ISO |
|
RGD |
PMID:30308939 |
RGD:151665105 |
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Cct5 |
chaperonin containing TCP1 subunit 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 2:82,591,750...82,602,903
Ensembl chr 2:82,590,630...82,602,930
|
|
G |
Cd163 |
CD163 molecule |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
|
|
G |
Cd44 |
CD44 molecule |
disease_progression |
ISO |
mRNA:splice variants:lung mRNA:increased expression:lung (human) |
RGD |
PMID:18091389 PMID:29537891 |
RGD:2289345, RGD:149735539 |
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cdc73 |
cell division cycle 73 |
exacerbates |
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:21692036 |
RGD:150537041 |
NCBI chr13:55,357,226...55,449,690
Ensembl chr13:55,357,226...55,449,656
|
|
G |
Cdh1 |
cadherin 1 |
|
IDA |
DNA:increased methylation |
RGD |
PMID:16329148 |
RGD:1599556 |
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdk12 |
cyclin-dependent kinase 12 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
|
|
NCBI chr10:83,201,177...83,256,906
Ensembl chr10:83,201,211...83,280,888 Ensembl chr10:83,201,211...83,280,888
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
|
ISO |
protein:increased expression:lung ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar RGD |
PMID:5377176 PMID:7652577 PMID:8528263 PMID:8968104 PMID:9228064 PMID:9425228 PMID:11756559 PMID:15880589 PMID:21801156 PMID:22804906 PMID:23384855 PMID:23546221 PMID:24256466 PMID:25157968 PMID:25741868 PMID:26619011 PMID:28492532 PMID:29774366 PMID:9751261 More...
|
RGD:13464277 |
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:10574260 |
RGD:13464325 |
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung |
ClinVar |
PMID:7780957 PMID:8521414 PMID:9324288 PMID:10491434 PMID:16234564 PMID:16896043 PMID:21462282 PMID:25157968 PMID:25741868 PMID:26619011 PMID:28492532 PMID:35001868 More...
|
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Chd4 |
chromodomain helicase DNA binding protein 4 |
susceptibility ameliorates |
ISO |
mRNA:increased expression:lung (human) DNA:missense mutation:CDS:p.D140E (rs7479004) (human) human cells in a mouse model |
RGD |
PMID:28486105 PMID:29667179 PMID:32228507 |
RGD:153323299, RGD:151660359, RGD:153323307 |
NCBI chr 4:157,898,503...157,931,632
Ensembl chr 4:157,899,391...157,931,541
|
|
G |
Chrna3 |
cholinergic receptor nicotinic alpha 3 subunit |
susceptibility |
ISO |
mRNA,protein:decreased expression:lung ClinVar Annotator: match by term: Lung adenocarcinoma DNA:SNPs:multiples:multiples (human) protein:increased expression:lung DNA:SNP: :rs8042374(human) associated with smoking; DNA:SNP: :rs1051730(human) |
ClinVar RGD |
PMID:27993330 PMID:19223495 PMID:25233467 PMID:24686516 PMID:24686516 PMID:20554942 More...
|
RGD:150524354, RGD:151347535, RGD:151347530, RGD:151347530, RGD:150527848 |
NCBI chr 8:55,401,668...55,415,165
Ensembl chr 8:55,401,702...55,415,165
|
|
G |
Chrna5 |
cholinergic receptor nicotinic alpha 5 subunit |
susceptibility disease_progression |
ISO |
DNA:SNP:cds: p.D398N (rs1696996)(human) ClinVar Annotator: match by term: Lung adenocarcinoma mRNA:increased expression:lung DNA:SNP: :rs503464(human) associated with smoking; DNA:SNPs: :rs2036527, rs684513, rs667282(human) DNA:SNP:cds: p.D398N(human) |
ClinVar RGD |
PMID:27993330 PMID:19223495 PMID:20124469 PMID:23314339 PMID:20554942 PMID:19577767 PMID:23430818 More...
|
RGD:150524354, RGD:150527851, RGD:150527849, RGD:150527848, RGD:150524359, RGD:150524356 |
NCBI chr 8:55,369,794...55,398,526
Ensembl chr 8:55,369,794...55,398,146
|
|
G |
Chrnb4 |
cholinergic receptor nicotinic beta 4 subunit |
|
ISO |
mRNA:increased expression:lung DNA:hypomethylation:promoter: |
RGD |
PMID:20124469 PMID:22945651 |
RGD:150527851, RGD:151361154 |
NCBI chr 8:55,417,583...55,437,027
Ensembl chr 8:55,418,313...55,437,027
|
|
G |
Clptm1l |
CLPTM1-like |
susceptibility no_association ameliorates |
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNP: :rs401681(human) DNA:SNP::rs77518573(human) DNA:SNP:: rs4975616(human) DNA:SNP::rs401681(human) DNA:SNP:: rs31490(human) mRNA:increased expression:lung |
CTD RGD |
PMID:22675468 PMID:24386361 PMID:31935503 PMID:19955392 PMID:24861918 PMID:23908149 PMID:23738012 PMID:24366883 PMID:24366883 More...
|
RGD:150537098, RGD:150530635, RGD:150530502, RGD:150530499, RGD:150530498, RGD:150530485, RGD:150530483, RGD:150530483 |
NCBI chr 1:29,667,545...29,683,530
Ensembl chr 1:29,667,545...29,683,530
|
|
G |
Cmtr2 |
cap methyltransferase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27158780 |
|
NCBI chr19:38,190,718...38,197,549
Ensembl chr19:38,190,642...38,197,804
|
|
G |
Col10a1 |
collagen type X alpha 1 chain |
disease_progression |
ISO |
mRNA:increased expression:lung |
RGD |
PMID:33324550 PMID:33324550 |
RGD:150429752, RGD:150429752 |
NCBI chr20:38,183,103...38,189,488
Ensembl chr20:38,182,494...38,189,494
|
|
G |
Crebbp |
CREB binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27158780 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
|
ISO |
protein:increased expression:lung (human) |
RGD |
PMID:23702648 |
RGD:150524280 |
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Csrp3 |
cysteine and glycine rich protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:98,528,067...98,546,647
Ensembl chr 1:98,528,068...98,546,653
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:9065402 PMID:9065403 PMID:9294210 PMID:9500465 PMID:9927029 PMID:10027390 PMID:10192393 PMID:10391090 PMID:10398436 PMID:10435629 PMID:10655994 PMID:10666372 PMID:11351304 PMID:11930117 PMID:11950921 PMID:12124804 PMID:15133491 PMID:23265383 PMID:24788118 PMID:25157968 PMID:25741868 PMID:26619011 PMID:26822237 More...
|
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
exacerbates |
ISO |
protein:increased expression:lung (human) mRNA:increased expression:lung (human) |
RGD |
PMID:30103827 PMID:19716197 |
RGD:152023735, RGD:152177480 |
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
ISO |
protein:increased expression:lung (human) |
RGD |
PMID:19358281 |
RGD:152177688 |
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
ameliorates |
ISO |
DNA:hypomethylation:promoter (human) mRNA:decreased expression:lung (human) human cell line in a mouse model |
RGD |
PMID:24736069 PMID:25519225 PMID:27793774 |
RGD:151361181, RGD:151665499, RGD:151665173 |
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18669584 |
|
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
|
|
G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Lung adenocarcinoma |
CTD ClinVar |
PMID:26206333 PMID:27993330 |
|
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
|
|
G |
Dll4 |
delta like canonical Notch ligand 4 |
treatment |
IEP |
|
RGD |
PMID:33628824 |
RGD:155663482 |
NCBI chr 3:106,317,114...106,327,004
Ensembl chr 3:106,316,986...106,326,931
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:21067377 PMID:21518476 PMID:22160010 PMID:22722925 PMID:22744846 PMID:22898539 PMID:22898541 PMID:24606448 PMID:24622842 PMID:24656771 PMID:25741868 PMID:26619011 PMID:26822784 PMID:26876596 PMID:27317772 PMID:27991732 PMID:28166811 PMID:28252636 PMID:28432085 PMID:28492532 PMID:28941052 PMID:29900417 PMID:30185810 PMID:30478443 PMID:31582562 PMID:31620784 PMID:31640986 PMID:31961069 PMID:32123902 PMID:32385248 PMID:34788385 More...
|
|
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
susceptibility |
ISO |
DNA:SNPs,haplotype:promoter:-283T >C,-579G>T(human) |
RGD |
PMID:15528220 |
RGD:9589086 |
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
|
|
G |
Dok1 |
docking protein 1 |
disease_progression |
ISO |
|
RGD |
PMID:20139980 |
RGD:152177521 |
NCBI chr 4:115,537,453...115,540,464
Ensembl chr 4:115,537,462...115,540,465
|
|
G |
Dok2 |
docking protein 2 |
disease_progression exacerbates |
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:20139980 PMID:30475228 PMID:20139980 PMID:24255704 |
RGD:152177521, RGD:152177492, RGD:152177521, RGD:152177493 |
NCBI chr15:45,826,984...45,841,409
Ensembl chr15:45,827,398...45,841,402
|
|
G |
Dok3 |
docking protein 3 |
disease_progression |
ISO |
|
RGD |
PMID:20139980 |
RGD:152177521 |
NCBI chr17:9,109,633...9,115,188
Ensembl chr17:9,109,597...9,115,188
|
|
G |
Dot1l |
DOT1 like histone lysine methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27158780 |
|
NCBI chr 7:8,918,764...8,959,474
Ensembl chr 7:8,917,786...8,956,475
|
|
G |
E2f1 |
E2F transcription factor 1 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:26695082 |
RGD:13464334 |
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E2f3 |
E2F transcription factor 3 |
|
ISO |
|
RGD |
PMID:16938365 |
RGD:13464341 |
NCBI chr17:34,601,756...34,679,139
Ensembl chr17:34,601,830...34,676,253
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
exacerbates |
ISO |
protein:increased expression:lung (human) |
RGD |
PMID:21554491 |
RGD:153298904 |
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
|
|
G |
Eef2k |
eukaryotic elongation factor-2 kinase |
ameliorates |
ISO |
Human cells in mouse model |
RGD |
PMID:30522114 |
RGD:153298964 |
NCBI chr 1:175,393,119...175,456,756
Ensembl chr 1:175,393,154...175,455,164
|
|
G |
Egf |
epidermal growth factor |
|
ISO |
DNA:polymorphism: :p.A61G (human) |
RGD |
PMID:26625757 |
RGD:11538684 |
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Adenocarcinoma of lung, somatic | ClinVar Annotator: match by term: Lung adenocarcinoma |
CTD ClinVar RGD |
PMID:2302402 PMID:11423618 PMID:15118073 PMID:15118125 PMID:15272417 PMID:15329413 PMID:15604253 PMID:15623594 PMID:15625347 PMID:15625379 PMID:15710947 PMID:15728811 PMID:15737014 PMID:15738541 PMID:15741570 PMID:15788655 PMID:15897572 PMID:15901872 PMID:15998907 PMID:16011858 PMID:16105816 PMID:16115929 PMID:16187797 PMID:16199108 PMID:16203769 PMID:16204011 PMID:16204070 PMID:16258541 PMID:16467085 PMID:16533793 PMID:16863509 PMID:16865253 PMID:16912157 PMID:16956694 PMID:17020982 PMID:17047654 PMID:17085664 PMID:17106442 PMID:17177598 PMID:17192902 PMID:17236554 PMID:17285735 PMID:17317677 PMID:17332364 PMID:17387341 PMID:17429313 PMID:17473653 PMID:17473659 PMID:17510392 PMID:17726540 PMID:17904685 PMID:17941001 PMID:18093943 PMID:18176089 PMID:18199554 PMID:18227510 PMID:18261621 PMID:18303429 PMID:18325048 PMID:18334834 PMID:18458038 PMID:18596266 PMID:18948947 PMID:18981003 PMID:18992959 PMID:19096301 PMID:19096302 PMID:19096324 PMID:19147750 PMID:19381876 PMID:19455431 PMID:19536777 PMID:19589612 PMID:19671738 PMID:19692680 PMID:19692684 PMID:19922469 PMID:20022809 PMID:20033049 PMID:20038723 PMID:20068085 PMID:20129249 PMID:20479403 PMID:20559149 PMID:20573926 PMID:20808254 PMID:20942962 PMID:21057810 PMID:21194487 PMID:21233402 PMID:21248300 PMID:21252721 PMID:21317742 PMID:21430269 PMID:21527506 PMID:21531810 PMID:21592614 PMID:21670455 PMID:21783417 PMID:21841502 PMID:21899495 PMID:21900837 PMID:21921847 PMID:22019513 PMID:22071784 PMID:22135231 PMID:22215752 PMID:22285168 PMID:22370314 PMID:22452895 PMID:22452896 PMID:22483783 PMID:22588155 PMID:22622260 PMID:22753918 PMID:22760226 PMID:22809298 PMID:22992668 PMID:23102728 PMID:23242437 PMID:23371856 PMID:23468066 PMID:23540867 PMID:23816960 PMID:23816963 PMID:23945392 PMID:23948351 PMID:24033266 PMID:24039832 PMID:24065731 PMID:24202392 PMID:24212795 PMID:24453288 PMID:24478319 PMID:24623981 PMID:24636847 PMID:24658966 PMID:24729716 PMID:24736066 PMID:24736080 PMID:24893891 PMID:24894453 PMID:25061320 PMID:25157968 PMID:25382819 PMID:25668228 PMID:25741868 PMID:25923549 PMID:25923550 PMID:26066407 PMID:26490356 PMID:26515464 PMID:26619011 PMID:26700910 PMID:26720284 PMID:27294619 PMID:27993330 PMID:28144970 PMID:28492532 PMID:28947568 PMID:29100434 PMID:29228562 PMID:30098700 PMID:30610926 PMID:31396478 PMID:31721094 PMID:32171629 PMID:32978515 PMID:32978518 PMID:33858029 PMID:1111234672 PMID:26824984 More...
|
RGD:126790475 |
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Ehmt2 |
euchromatic histone lysine methyltransferase 2 |
disease_progression |
ISO |
|
RGD |
PMID:20940408 |
RGD:9589170 |
NCBI chr20:3,919,623...3,936,751
Ensembl chr20:3,919,624...3,941,547
|
|
G |
Eif2b1 |
eukaryotic translation initiation factor 2B subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr12:32,025,593...32,033,848
Ensembl chr12:32,025,557...32,046,601
|
|
G |
Eif2b4 |
eukaryotic translation initiation factor 2B subunit delta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24366584 |
|
NCBI chr 6:25,183,177...25,188,832
Ensembl chr 6:25,183,186...25,188,829
|
|
G |
Eif2b5 |
eukaryotic translation initiation factor 2B subunit epsilon |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24366584 |
|
NCBI chr11:80,394,433...80,404,468
Ensembl chr11:80,394,433...80,404,419
|
|
G |
Eif3e |
eukaryotic translation initiation factor 3 subunit E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 7:74,339,848...74,372,483
Ensembl chr 7:74,339,828...74,373,096
|
|
G |
Eml4 |
EMAP like 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22980554 PMID:22999080 |
|
NCBI chr 6:11,219,545...11,334,824
Ensembl chr 6:11,219,566...11,334,879
|
|
G |
Emx2 |
empty spiracles homeobox 2 |
exacerbates |
ISO |
mRNA,protein:decreased expression:lung (human) |
RGD |
PMID:21726823 |
RGD:153323303 |
NCBI chr 1:258,626,584...258,633,594
Ensembl chr 1:258,626,584...258,633,594
|
|
G |
Eno1 |
enolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 PMID:27602772 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
|
|
G |
Ep300 |
E1A binding protein p300 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27158780 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Epha5 |
EPH receptor A5 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:16140923 |
|
NCBI chr14:23,653,393...24,020,129
Ensembl chr14:23,653,393...24,017,317
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
disease_progression |
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar RGD |
PMID:15457249 PMID:15753357 PMID:16638863 PMID:18334834 PMID:22325357 PMID:22761469 PMID:22908275 PMID:24033266 PMID:26619011 PMID:26824984 More...
|
RGD:126790475 |
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
disease_progression |
ISO |
|
RGD |
PMID:26824984 |
RGD:126790475 |
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
|
|
G |
Erbb4 |
erb-b2 receptor tyrosine kinase 4 |
disease_progression |
ISO |
|
RGD |
PMID:26824984 |
RGD:126790475 |
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21327329 |
|
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
|
|
G |
Ercc6 |
ERCC excision repair 6, chromatin remodeling factor |
|
ISO |
mRNA, protein:increased expression:lung (human) |
RGD |
PMID:31615563 |
RGD:155260344 |
NCBI chr16:7,764,983...7,835,587
Ensembl chr16:7,765,013...7,835,587
|
|
G |
Ercc6l |
ERCC excision repair 6 like, spindle assembly checkpoint helicase |
exacerbates |
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:35150321 |
RGD:155260359 |
NCBI chr X:67,245,414...67,261,222
Ensembl chr X:67,245,414...67,280,756
|
|
G |
Ergic3 |
ERGIC and golgi 3 |
ameliorates disease_progression |
ISO |
mRNA,protein:increased expression:lung (human) |
RGD |
PMID:27588471 PMID:23374247 |
RGD:153323314, RGD:151708716 |
NCBI chr 3:144,525,059...144,534,813
Ensembl chr 3:144,525,092...144,534,813
|
|
G |
Erp29 |
endoplasmic reticulum protein 29 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr12:35,089,698...35,095,952
Ensembl chr12:35,089,707...35,096,376
|
|
G |
Esco2 |
establishment of sister chromatid cohesion N-acetyltransferase 2 |
ameliorates |
ISO |
|
RGD |
PMID:33573689 |
RGD:155791670 |
NCBI chr15:40,034,566...40,052,295
Ensembl chr15:40,034,568...40,055,306
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
disease_progression |
ISO |
|
RGD |
PMID:24097870 |
RGD:126781716 |
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:29254206 |
RGD:151665107 |
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fasn |
fatty acid synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fbl |
fibrillarin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:83,469,832...83,478,932
Ensembl chr 1:83,469,832...83,478,932
|
|
G |
Fbxw7 |
F-box and WD repeat domain containing 7 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung |
ClinVar |
PMID:26619011 |
|
NCBI chr 2:170,149,706...170,311,536
Ensembl chr 2:170,149,694...170,309,941
|
|
G |
Fes |
FES proto-oncogene, tyrosine kinase |
treatment |
ISO |
human cells in a mouse model |
RGD |
PMID:31573955 |
RGD:153323295 |
NCBI chr 1:134,337,698...134,346,934
Ensembl chr 1:134,337,698...134,346,934
|
|
G |
Fgf10 |
fibroblast growth factor 10 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 2:50,801,171...50,878,218
Ensembl chr 2:50,800,992...50,876,866
|
|
G |
Fgf18 |
fibroblast growth factor 18 |
|
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:19296538 |
RGD:150429981 |
NCBI chr10:17,706,011...17,737,702
Ensembl chr10:17,706,174...17,736,818
|
|
G |
Fgf9 |
fibroblast growth factor 9 |
disease_progression |
ISO |
protein:increased expression:lung (human) mRNA:decreased expression:lung (human) |
RGD |
PMID:19296538 PMID:19358281 PMID:20464547 |
RGD:150429981 RGD:152177688, RGD:152975620 |
NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:17525745 PMID:18552176 PMID:22238366 PMID:23002168 PMID:23908597 PMID:25157968 PMID:26619011 More...
|
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung |
ClinVar |
PMID:1908846 PMID:7773297 PMID:8640234 PMID:8858131 PMID:9438390 PMID:9677066 PMID:10073901 PMID:10471491 PMID:10696568 PMID:11241532 PMID:11529856 PMID:12833394 PMID:15772091 PMID:16841094 PMID:18642369 PMID:20301540 PMID:20420824 PMID:22045636 PMID:25157968 PMID:25606676 PMID:25614871 PMID:25741868 PMID:26619011 PMID:28492532 PMID:29593476 PMID:31299979 PMID:36135330 PMID:36474027 More...
|
|
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
|
|
G |
Fgfr4 |
fibroblast growth factor receptor 4 |
disease_progression exacerbates |
ISO |
DNA:SNP:exon 9: p.G288R (human) DNA:SNP:exon 9: p.G388R (rs351855)(human) human cells in mouse model |
RGD |
PMID:16061909 PMID:19296538 PMID:29402970 |
RGD:150429976, RGD:150429981, RGD:150429984 |
NCBI chr17:9,461,541...9,476,268
Ensembl chr17:9,461,547...9,476,242
|
|
G |
Fkbp11 |
FKBP prolyl isomerase 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 7:129,871,870...129,877,760
Ensembl chr 7:129,871,870...129,875,303
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Foxa1 |
forkhead box A1 |
|
ISO |
mRNA:increased expression:lung CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:34254728 PMID:12234996 PMID:29072684 |
RGD:151665758, RGD:151665822 |
NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188
|
|
G |
Foxo3 |
forkhead box O3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19380174 |
|
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Foxp1 |
forkhead box P1 |
|
IEP |
mRNA:decreased expression:lung (rat) |
RGD |
PMID:16023287 |
RGD:11561933 |
NCBI chr 4:131,559,599...132,155,092
Ensembl chr 4:131,564,756...132,112,258
|
|
G |
Foxp2 |
forkhead box P2 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 4:43,133,827...43,712,442
Ensembl chr 4:43,133,912...43,711,683
|
|
G |
Foxp4 |
forkhead box P4 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 9:13,058,506...13,115,406
Ensembl chr 9:13,058,476...13,114,879
|
|
G |
Fpr2 |
formyl peptide receptor 2 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 1:58,776,592...58,785,227
Ensembl chr 1:58,776,752...58,786,019
|
|
G |
Frzb |
frizzled-related protein |
severity |
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:27623992 |
RGD:32716395 |
NCBI chr 3:65,332,274...65,365,208
Ensembl chr 3:65,332,277...65,365,208
|
|
G |
Fubp1 |
far upstream element binding protein 1 |
|
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:32481602 |
RGD:151361197 |
NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
|
|
G |
Gar1 |
GAR1 ribonucleoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 2:218,375,231...218,382,509
Ensembl chr 2:218,375,353...218,382,524
|
|
G |
Gart |
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr11:30,864,896...30,891,125
Ensembl chr11:30,865,889...30,891,125
|
|
G |
Gjb2 |
gap junction protein, beta 2 |
|
IDA |
DNA, mRNA:hypermethylation, decreased expression:lung |
RGD |
PMID:16637067 |
RGD:11568669 |
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
|
|
G |
Gnas |
GNAS complex locus |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung |
ClinVar |
PMID:1517386 PMID:1594625 PMID:1944469 PMID:2549426 PMID:3720010 PMID:7739708 PMID:8766942 PMID:9626141 PMID:10571700 PMID:11093740 PMID:12727968 PMID:12970318 PMID:15126527 PMID:15952988 PMID:16507630 PMID:16543670 PMID:17873334 PMID:20197676 PMID:21835143 PMID:23403822 PMID:23536913 PMID:23843956 PMID:24855271 PMID:25157968 PMID:25719192 PMID:25741868 PMID:26341786 PMID:26574629 PMID:26619011 PMID:27398169 PMID:27506760 PMID:28492532 PMID:29991465 PMID:30702195 More...
|
|
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
|
|
G |
Gng11 |
G protein subunit gamma 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24366584 |
|
NCBI chr 4:32,023,003...32,028,443
Ensembl chr 4:32,023,003...32,028,442
|
|
G |
Gnpnat1 |
glucosamine-phosphate N-acetyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr15:18,596,180...18,608,854
Ensembl chr15:18,596,442...18,608,739
|
|
G |
Golm1 |
golgi membrane protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr17:4,995,925...5,044,329
Ensembl chr17:4,996,104...5,034,057
|
|
G |
Gpi |
glucose-6-phosphate isomerase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:86,828,211...86,856,077
Ensembl chr 1:86,828,216...86,856,086
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
|
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:23374247 |
RGD:151708716 |
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Grwd1 |
glutamate-rich WD repeat containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:96,301,260...96,306,962
Ensembl chr 1:96,301,261...96,307,201
|
|
G |
H1f10 |
H1.10 linker histone |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 4:120,440,515...120,441,578
Ensembl chr 4:120,440,870...120,441,448
|
|
G |
Hells |
helicase, lymphoid specific |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
|
|
G |
Hk1 |
hexokinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr20:30,230,488...30,332,099
Ensembl chr20:30,230,486...30,332,131
|
|
G |
Hk2 |
hexokinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
|
|
G |
Hmgb2 |
high mobility group box 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24366584 PMID:27602772 |
|
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140
|
|
G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
|
|
G |
Hoxb7 |
homeo box B7 |
severity |
ISO |
protein:increased expression:lung epithelium (human) |
RGD |
PMID:22911672 |
RGD:10402176 |
NCBI chr10:81,252,616...81,256,034
Ensembl chr10:81,252,553...81,256,034
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adenocarcinoma of lung ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
CTD ClinVar |
PMID:1904555 PMID:3510078 PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17384584 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19255327 PMID:19371735 PMID:19382114 PMID:19669404 PMID:19773371 PMID:20301680 PMID:20660566 PMID:20859122 PMID:20937837 PMID:20979192 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23751039 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24390138 PMID:24803665 PMID:25157968 PMID:25326635 PMID:25695684 PMID:25741868 PMID:25815234 PMID:25914166 PMID:26467025 PMID:26558449 PMID:26619011 PMID:26778095 PMID:27195699 PMID:27283355 PMID:27444071 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28328122 PMID:28492532 PMID:29493581 PMID:30055033 PMID:30138938 PMID:30191474 PMID:31222966 PMID:31394527 PMID:31560489 PMID:31564432 PMID:31775759 PMID:32165824 PMID:32371413 PMID:32732226 PMID:33027564 PMID:33372952 PMID:34008892 PMID:34958143 PMID:168335863 More...
|
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hsd17b10 |
hydroxysteroid (17-beta) dehydrogenase 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr X:21,089,142...21,091,603
Ensembl chr X:21,089,122...21,109,488
|
|
G |
Hsp90b1 |
heat shock protein 90 beta family member 1 |
|
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:23374247 |
RGD:151708716 |
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Htr4 |
5-hydroxytryptamine receptor 4 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr18:55,765,981...55,949,921
Ensembl chr18:55,766,725...55,949,321
|
|
G |
Htra1 |
HtrA serine peptidase 1 |
disease_progression |
ISO |
human cells in mouse model |
RGD |
PMID:24356998 |
RGD:152975621 |
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
disease_progression |
ISO |
mRNA:increased expression:lung (human) ClinVar Annotator: match by term: Adenocarcinoma of lung protein:increased expression:blood plasma (human) |
ClinVar RGD |
PMID:18772396 PMID:19657110 PMID:19798509 PMID:19818334 PMID:20946881 PMID:21352804 PMID:21446021 PMID:22160010 PMID:22397365 PMID:22417203 PMID:22898539 PMID:23558169 PMID:24606448 PMID:25043048 PMID:25157968 PMID:25741868 PMID:26619011 PMID:27993330 PMID:30231226 PMID:36201590 PMID:29537891 PMID:24046070 More...
|
RGD:149735539, RGD:149735540 |
NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
severity |
ISO |
protein:increased expression:lung (human) protein:increased expression:blood serum (human) |
RGD |
PMID:30128035 PMID:29465809 |
RGD:149735564, RGD:149735567 |
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
|
|
G |
Igf2r |
insulin-like growth factor 2 receptor |
|
IAGP |
mRNA:deletions: :c.3698_4902del, c.3366_4902del, c.3817_4697del (rat) |
RGD |
PMID:12503077 |
RGD:1298968 |
NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
|
|
G |
Ikzf1 |
IKAROS family zinc finger 1 |
exacerbates ameliorates |
ISO |
protein:increased expression:lung (human) mRNA:increased expression:lung (human) |
RGD |
PMID:33738286 PMID:32787735 |
RGD:151347632, RGD:150540324 |
NCBI chr14:86,255,065...86,340,839
Ensembl chr14:86,255,065...86,342,416
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
disease_progression severity |
ISO |
mRNA:altered expression:lung (human) mRNA:increased expression:lung (human) |
RGD |
PMID:31921619 PMID:29942094 |
RGD:152998982, RGD:152998998 |
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
|
|
G |
Impdh2 |
inosine monophosphate dehydrogenase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 8:109,256,705...109,261,365
Ensembl chr 8:109,256,728...109,261,359
|
|
G |
Ipo4 |
importin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr15:29,117,365...29,127,382
Ensembl chr15:29,117,365...29,127,285
|
|
G |
Ipo5 |
importin 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr15:97,990,755...98,041,074
Ensembl chr15:98,005,299...98,041,126
|
|
G |
Iqsec1 |
IQ motif and Sec7 domain ArfGEF 1 |
disease_progression |
ISO |
|
RGD |
PMID:24902879 |
RGD:153350085 |
NCBI chr 4:123,168,719...123,488,300
Ensembl chr 4:123,168,719...123,488,172
|
|
G |
Irak3 |
interleukin-1 receptor-associated kinase 3 |
|
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:21278795 |
RGD:36049796 |
NCBI chr 7:55,653,949...55,714,371
Ensembl chr 7:55,653,962...55,713,121
|
|
G |
Ireb2 |
iron responsive element binding protein 2 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 8:55,228,080...55,311,613
Ensembl chr 8:55,228,085...55,311,611
|
|
G |
Jak2 |
Janus kinase 2 |
treatment |
ISO |
human cells in mouse model |
RGD |
PMID:27025877 |
RGD:11574134 |
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24366584 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Kcnj4 |
potassium inwardly-rectifying channel, subfamily J, member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30512237 |
|
NCBI chr 7:111,047,097...111,074,151
Ensembl chr 7:111,047,094...111,074,151
|
|
G |
Klf5 |
KLF transcription factor 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27158780 |
|
NCBI chr15:76,060,320...76,079,445
Ensembl chr15:76,064,258...76,079,445
|
|
G |
Kmt2c |
lysine methyltransferase 2C |
disease_progression onset |
ISO |
|
RGD |
PMID:32867667 PMID:30821106 |
RGD:151356760, RGD:151356761 |
NCBI chr 4:9,620,638...9,834,787
Ensembl chr 4:9,609,627...9,833,539
|
|
G |
Kpna2 |
karyopherin subunit alpha 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:91,933,951...91,946,115
Ensembl chr10:91,933,951...91,946,150
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
ISO |
DNA:point mutation:CDS:p.G12C (human) ClinVar Annotator: match by term: Adenocarcinoma of lung CTD Direct Evidence: marker/mechanism |
ClinVar CTD RGD |
PMID:2278970 PMID:3122217 PMID:6320174 PMID:8143615 PMID:8425762 PMID:11745231 PMID:12460918 PMID:15696205 PMID:16051643 PMID:16361624 PMID:16434492 PMID:16618717 PMID:17384584 PMID:17704260 PMID:18316791 PMID:18794081 PMID:19018267 PMID:19075190 PMID:19114683 PMID:19255327 PMID:19679400 PMID:19773371 PMID:19794967 PMID:20921462 PMID:20921465 PMID:21228335 PMID:21975775 PMID:22071784 PMID:22135231 PMID:22282465 PMID:22407852 PMID:22722830 PMID:23014527 PMID:23182985 PMID:23325582 PMID:23406027 PMID:24045185 PMID:25044103 PMID:25157968 PMID:25184679 PMID:25741868 PMID:26242988 PMID:26463840 PMID:26619011 PMID:28492532 PMID:31666701 PMID:35658005 PMID:11745231 More...
|
RGD:1600465 |
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Ldha |
lactate dehydrogenase A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Lect2 |
leukocyte cell-derived chemotaxin 2 |
ameliorates |
ISO |
human cells in mouse model |
RGD |
PMID:30453282 |
RGD:153323337 |
NCBI chr17:8,044,759...8,050,983
Ensembl chr17:8,044,759...8,050,983
|
|
G |
Lmna |
lamin A/C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr 2:173,939,751...173,960,423
Ensembl chr 2:173,939,751...173,960,423
|
|
G |
Lmnb1 |
lamin B1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
|
|
G |
Lrp1b |
LDL receptor related protein 1B |
disease_progression |
ISO |
DNA:mutations:multiple: (human) |
RGD |
PMID:18948947 |
RGD:11064706 |
NCBI chr 3:24,594,302...26,715,037
Ensembl chr 3:24,594,991...26,715,505
|
|
G |
Lrrc56 |
leucine rich repeat containing 56 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:1904555 PMID:3510078 PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17384584 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19255327 PMID:19371735 PMID:19382114 PMID:19669404 PMID:19773371 PMID:20301680 PMID:20660566 PMID:20859122 PMID:20937837 PMID:20979192 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23751039 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24390138 PMID:24803665 PMID:25157968 PMID:25326635 PMID:25695684 PMID:25741868 PMID:25815234 PMID:25914166 PMID:26467025 PMID:26619011 PMID:26778095 PMID:27195699 PMID:27283355 PMID:27444071 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28328122 PMID:28492532 PMID:29493581 PMID:30055033 PMID:30138938 PMID:30191474 PMID:31222966 PMID:31394527 PMID:31560489 PMID:31564432 PMID:31775759 PMID:32165824 PMID:32371413 PMID:32732226 PMID:33027564 PMID:33372952 PMID:34008892 PMID:34958143 PMID:168335863 More...
|
|
NCBI chr 1:196,299,843...196,315,170
Ensembl chr 1:196,299,846...196,315,172
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma mRNA:increased expression:lung (human) |
CTD ClinVar RGD |
PMID:18632602 PMID:21383288 PMID:22135231 PMID:22197931 PMID:22588879 PMID:23444215 PMID:24448821 PMID:25157968 PMID:25741868 PMID:26619011 PMID:29643386 PMID:29254206 More...
|
RGD:151665107 |
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
severity |
ISO |
|
RGD |
PMID:21896780 PMID:12231543 |
RGD:150429783, RGD:150429821 |
NCBI chr10:50,343,227...50,447,956
Ensembl chr10:50,344,915...50,447,993
|
|
G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
exacerbates |
ISO |
human gene in a mouse model |
RGD |
PMID:34236045 |
RGD:155230828 |
NCBI chr12:2,591,312...2,600,534
Ensembl chr12:2,591,219...2,604,222
|
|
G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
exacerbates |
ISO |
|
RGD |
PMID:23533274 |
RGD:151356978 |
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
|
|
G |
Map4k4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
ameliorates exacerbates |
ISO |
human cell line in a mouse model mRNA, protein:increased expression:lung (human) |
RGD |
PMID:22824148 PMID:28306189 PMID:33510968 |
RGD:151347677, RGD:151347678, RGD:151347681 |
NCBI chr 9:42,200,708...42,326,708
Ensembl chr 9:42,200,278...42,326,698
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
exacerbates |
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:31969449 |
RGD:151665505 |
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
severity treatment |
ISO |
mRNA:increased expression:lung (human) human cells in mouse model |
RGD |
PMID:31200834 PMID:31200834 |
RGD:151356911, RGD:151356911 |
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Meox1 |
mesenchyme homeobox 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:34837450 |
|
NCBI chr10:86,818,450...86,837,563
Ensembl chr10:86,818,478...86,837,660
|
|
G |
Mier3 |
MIER family member 3 |
ameliorates |
ISO |
|
RGD |
PMID:35117188 |
RGD:407571696 |
NCBI chr 2:43,287,546...43,316,422
Ensembl chr 2:43,287,916...43,316,136
|
|
G |
Mir127 |
microRNA 127 |
treatment |
ISO |
Human cells in mouse model |
RGD |
PMID:27869168 |
RGD:152995353 |
NCBI chr 6:128,546,215...128,546,311
Ensembl chr 6:128,546,215...128,546,311
|
|
G |
Mir154 |
microRNA 154 |
|
ISO |
associated with nicotine dependence; RNA:decreased expression:blood serum (human) |
RGD |
PMID:25386559 |
RGD:152995475 |
NCBI chr 6:128,752,947...128,753,030
Ensembl chr 6:128,752,947...128,753,030
|
|
G |
Mir20a |
microRNA 20a |
|
ISO |
|
RGD |
PMID:26560875 |
RGD:11572141 |
NCBI chr15:92,181,084...92,181,168
Ensembl chr15:92,181,084...92,181,168
|
|
G |
Mir21 |
microRNA 21 |
disease_progression |
ISO |
RNA:increased expression:lung (human) miRNA:increased expression:sputum (human) |
RGD |
PMID:29892003 PMID:27777637 |
RGD:152998892, RGD:152998954 |
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mir31 |
microRNA 31 |
severity disease_progression |
ISO |
RNA:increased expression:lung (human) |
RGD |
PMID:26657862 PMID:29367106 PMID:23946296 PMID:27215092 |
RGD:11343268, RGD:152998945, RGD:152998944, RGD:11250998 |
NCBI chr 5:103,599,038...103,599,143
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
disease_progression |
ISO |
protein:altered expression:lung (human) |
RGD |
PMID:26942465 |
RGD:152999419 |
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mlh1 |
mutL homolog 1 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:15340264 PMID:17510385 PMID:18307539 PMID:19419416 PMID:22136435 PMID:22703879 PMID:24033266 PMID:24728327 PMID:25157968 PMID:25741868 PMID:25823662 PMID:27993330 PMID:28492532 More...
|
|
NCBI chr 8:111,196,468...111,233,721
Ensembl chr 8:111,196,468...111,233,617
|
|
G |
Mre11 |
MRE11 homolog, double strand break repair nuclease |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 8:11,618,876...11,680,451
Ensembl chr 8:11,632,354...11,678,279
|
|
G |
Mrpl12 |
mitochondrial ribosomal protein L12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:105,758,410...105,762,913
Ensembl chr10:105,758,410...105,762,913
|
|
G |
Mrps5 |
mitochondrial ribosomal protein S5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 3:114,821,046...114,837,291
Ensembl chr 3:114,821,046...114,837,291
|
|
G |
Ms4a1 |
membrane spanning 4-domains A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22514692 |
|
NCBI chr 1:207,906,370...207,927,028
Ensembl chr 1:207,906,374...207,918,512
|
|
G |
Msh2 |
mutS homolog 2 |
no_association |
ISO |
DNA:polymorphisms:introns:IVS10+12A>G, IVS12-6T>C (human) DNA:polymorphisms:promoter, intron:-118T>C, IVS1+9G>C (human) |
RGD |
PMID:16614121 PMID:16614121 |
RGD:11065547, RGD:11065547 |
NCBI chr 6:6,813,793...6,872,960
Ensembl chr 6:6,813,795...6,872,938
|
|
G |
Msh3 |
mutS homolog 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21327329 |
|
NCBI chr 2:23,444,326...23,585,777
|
|
G |
Msh6 |
mutS homolog 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21327329 |
|
NCBI chr 6:6,562,631...6,579,995
Ensembl chr 6:6,562,632...6,579,956
|
|
G |
Muc1 |
mucin 1, cell surface associated |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:8694545 |
RGD:5131260 |
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
|
|
G |
Muc4 |
mucin 4, cell surface associated |
disease_progression |
ISO |
protein:increased expression:trachea |
RGD |
PMID:17126950 |
RGD:5131208 |
NCBI chr11:68,008,245...68,053,242
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung, somatic | ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
ISO |
human cell line in mouse model CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Lung adenocarcinoma |
CTD ClinVar RGD |
PMID:25157968 PMID:26619011 PMID:26656844 PMID:27602772 PMID:20033209 |
RGD:7207787 |
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
treatment ameliorates |
ISO |
mouse cell line in a mouse model |
RGD |
PMID:32140881 PMID:30712876 |
RGD:150520172, RGD:150540309 |
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Naa10 |
N(alpha)-acetyltransferase 10, NatA catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr X:151,656,056...151,661,304
Ensembl chr X:151,656,056...151,661,252
|
|
G |
Naip6 |
NLR family, apoptosis inhibitory protein 6 |
ameliorates |
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr 2:31,507,423...31,559,098
Ensembl chr 2:31,507,424...31,570,542
|
|
G |
Ncapg |
non-SMC condensin I complex, subunit G |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34419073 |
|
NCBI chr14:65,403,930...65,432,902
Ensembl chr14:65,404,163...65,432,902
|
|
G |
Ncl |
nucleolin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 9:86,999,588...87,008,112
Ensembl chr 9:86,998,019...87,008,136
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:26619011 PMID:29018201 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nkx2-1 |
NK2 homeobox 1 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 6:73,996,601...74,001,483
Ensembl chr 6:73,996,601...73,999,791
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nop56 |
NOP56 ribonucleoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 3:117,476,963...117,481,847
Ensembl chr 3:117,477,053...117,481,841
|
|
G |
Nop58 |
NOP58 ribonucleoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 9:61,120,939...61,144,810
Ensembl chr 9:61,120,929...61,144,810
|
|
G |
Notch1 |
notch receptor 1 |
treatment |
IEP |
|
RGD |
PMID:33628824 |
RGD:155663482 |
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Npm1 |
nucleophosmin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:17,741,512...17,751,626
Ensembl chr10:17,739,941...17,751,645
|
|
G |
Npm3 |
nucleophosmin/nucleoplasmin, 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:244,595,638...244,597,623
Ensembl chr 1:244,595,644...244,597,591
|
|
G |
Nras |
NRAS proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung |
ClinVar |
PMID:1654209 PMID:2278970 PMID:2674680 PMID:3122217 PMID:6587382 PMID:8120410 PMID:10821536 PMID:12460918 PMID:12727991 PMID:14508525 PMID:15899789 PMID:16273091 PMID:16291983 PMID:16434492 PMID:17699718 PMID:18390968 PMID:18633438 PMID:18668139 PMID:18948947 PMID:19075190 PMID:19657110 PMID:19880792 PMID:19966803 PMID:20130576 PMID:20149136 PMID:20179705 PMID:20406486 PMID:20619739 PMID:20736745 PMID:21107323 PMID:21305640 PMID:21576590 PMID:21729679 PMID:21829508 PMID:22407852 PMID:22499344 PMID:22718121 PMID:22761467 PMID:22773810 PMID:23076151 PMID:23392294 PMID:23400451 PMID:23414587 PMID:23515407 PMID:23538902 PMID:23569304 PMID:23614898 PMID:24006476 PMID:24033266 PMID:24148783 PMID:24370118 PMID:24671188 PMID:25157968 PMID:25348872 PMID:25695684 PMID:25741868 PMID:26619011 PMID:26821351 PMID:27050078 PMID:28492532 PMID:28780248 More...
|
|
NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626
|
|
G |
Nudt21 |
nudix hydrolase 21 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr19:10,974,800...10,993,841
Ensembl chr19:10,974,241...10,991,682
|
|
G |
Nuf2 |
NUF2 component of NDC80 kinetochore complex |
disease_progression |
ISO |
|
RGD |
PMID:32226507 |
RGD:28912743 |
NCBI chr13:81,693,675...81,722,765
Ensembl chr13:81,693,598...81,722,766
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23951099 |
|
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
|
|
G |
Pabpc4 |
poly(A) binding protein, cytoplasmic 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 5:135,563,142...135,578,985
Ensembl chr 5:135,563,562...135,578,979
|
|
G |
Pacrg |
parkin coregulated |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:12719539 |
|
NCBI chr 1:49,882,671...50,305,564
Ensembl chr 1:49,882,630...50,305,430
|
|
G |
Pcbd1 |
pterin-4 alpha-carbinolamine dehydratase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr20:29,037,545...29,044,322
Ensembl chr20:28,953,864...29,044,292 Ensembl chr20:28,953,864...29,044,292
|
|
G |
Pign |
phosphatidylinositol glycan anchor biosynthesis, class N |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr13:21,659,092...21,812,932
Ensembl chr13:21,662,455...21,806,790
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
CTD ClinVar |
PMID:15016963 PMID:15254419 PMID:15520168 PMID:15608678 PMID:15647370 PMID:15805248 PMID:15930273 PMID:16906227 PMID:16930767 PMID:17376864 PMID:17673550 PMID:18074223 PMID:18676830 PMID:18725974 PMID:19029981 PMID:19223544 PMID:19366826 PMID:19513541 PMID:19903786 PMID:20453058 PMID:20581867 PMID:20593314 PMID:20619739 PMID:21078999 PMID:21430269 PMID:21558396 PMID:21824802 PMID:22135231 PMID:22162582 PMID:22162589 PMID:22209294 PMID:22271473 PMID:22357840 PMID:22370636 PMID:22658544 PMID:22729222 PMID:22729223 PMID:22729224 PMID:23066039 PMID:23100325 PMID:23246288 PMID:23408298 PMID:23888070 PMID:23946963 PMID:24033266 PMID:24265155 PMID:24497998 PMID:24559322 PMID:24782230 PMID:25157968 PMID:25599672 PMID:25681199 PMID:25741868 PMID:25880439 PMID:25915946 PMID:26266975 PMID:26266985 PMID:26351730 PMID:26619011 PMID:26627007 PMID:26637981 PMID:26822237 PMID:26851524 PMID:27126994 PMID:27626068 PMID:27631024 PMID:28151489 PMID:28425981 PMID:28492532 PMID:28566443 PMID:28941273 PMID:29446767 PMID:29549527 PMID:29661094 PMID:29758562 PMID:29988677 PMID:30063105 PMID:30376034 PMID:30543347 PMID:31536475 PMID:31775759 PMID:32778138 PMID:34008892 PMID:34496175 PMID:34568242 PMID:34606700 PMID:36474027 PMID:37667289 PMID:37712948 More...
|
|
NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
|
ISO |
mRNA:decreased expression:lung |
RGD |
PMID:26695082 |
RGD:13464334 |
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
|
|
G |
Pitx2 |
paired-like homeodomain 2 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 2:217,717,738...217,737,293
Ensembl chr 2:217,717,693...217,737,293
|
|
G |
Plcg1 |
phospholipase C, gamma 1 |
exacerbates |
ISO |
protein:decreased expression:lung (human) |
RGD |
PMID:33077911 |
RGD:151356960 |
NCBI chr 3:149,385,587...149,416,330
Ensembl chr 3:149,385,587...149,416,330
|
|
G |
Plod2 |
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
disease_progression |
ISO |
|
RGD |
PMID:29072684 |
RGD:151665822 |
NCBI chr 8:93,084,548...93,167,255
Ensembl chr 8:93,084,513...93,167,255
|
|
G |
Pold1 |
DNA polymerase delta 1, catalytic subunit |
exacerbates |
ISO |
protein:increased expression:lung (human) |
RGD |
PMID:33442399 |
RGD:153323317 |
NCBI chr 1:95,025,462...95,041,559
Ensembl chr 1:95,025,499...95,036,465
|
|
G |
Polr1d |
RNA polymerase I and III subunit D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr12:7,970,592...8,004,157
Ensembl chr12:7,970,595...8,005,624
|
|
G |
Ppan |
peter pan homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 8:19,423,908...19,427,941
Ensembl chr 8:19,423,961...19,427,938
|
|
G |
Ppp2r1a |
protein phosphatase 2 scaffold subunit A alpha |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung |
ClinVar |
PMID:25741868 PMID:26168268 PMID:26619011 PMID:28492532 PMID:31687265 PMID:33106617 PMID:34930662 More...
|
|
NCBI chr 1:60,540,223...60,559,467
Ensembl chr 1:60,540,194...60,560,129
|
|
G |
Ppp3ca |
protein phosphatase 3 catalytic subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27158780 |
|
NCBI chr 2:225,165,981...225,440,978
Ensembl chr 2:225,165,766...225,438,974
|
|
G |
Pramex1 |
PRAME like, X-linked 1 |
|
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:27241212 |
RGD:11535020 |
NCBI chr X:98,567,994...98,574,654
Ensembl chr X:98,569,415...98,572,096
|
|
G |
Prdm1 |
PR/SET domain 1 |
exacerbates |
ISO |
|
RGD |
PMID:28378641 |
RGD:150530469 |
NCBI chr20:47,959,858...47,981,488
Ensembl chr20:47,959,858...47,981,488
|
|
G |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:12719539 |
|
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
|
|
G |
Psat1 |
phosphoserine aminotransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682
|
|
G |
Ptch1 |
patched 1 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar RGD |
PMID:27993330 PMID:28492532 PMID:33359005 |
RGD:150524339 |
NCBI chr17:1,542,705...1,607,730
Ensembl chr17:1,542,877...1,607,333
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung |
ClinVar |
PMID:26619011 PMID:26822237 |
|
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
|
|
G |
Ptpn13 |
protein tyrosine phosphatase, non-receptor type 13 |
exacerbates susceptibility |
ISO |
mRNA,protein:decreased expression:lung DNA:missense mutations:cds:p.I1522M, p.Y2081D (human) |
RGD |
PMID:22245727 PMID:33536603 PMID:19672627 |
RGD:152176663, RGD:152975626, RGD:152176665 |
NCBI chr14:6,108,202...6,282,619
Ensembl chr14:6,108,211...6,282,563
|
|
G |
Ptprb |
protein tyrosine phosphatase, receptor type, B |
disease_progression |
ISO |
mRNA:altered expression:lung (human) mRNA:decreased expression:lung (human) |
RGD |
PMID:29254206 PMID:7981622 |
RGD:151665107, RGD:151665112 |
NCBI chr 7:51,953,375...52,034,751
Ensembl chr 7:51,930,015...52,034,748
|
|
G |
Ptprj |
protein tyrosine phosphatase, receptor type, J |
susceptibility |
ISO |
DNA:missense mutations:cds:p.R326Q, p.Q276P (human) |
RGD |
PMID:19672627 |
RGD:152176665 |
NCBI chr 3:76,405,917...76,561,842
Ensembl chr 3:76,405,927...76,562,260
|
|
G |
Rac1 |
Rac family small GTPase 1 |
exacerbates ameliorates |
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:31779616 PMID:32366477 |
RGD:152998910, RGD:153345550 |
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:1760348 PMID:8601312 PMID:10064593 PMID:12077328 PMID:17603482 PMID:17603483 PMID:19568997 PMID:19953625 PMID:20052757 PMID:20301557 PMID:21440552 PMID:21784453 PMID:22389993 PMID:23312806 PMID:23321623 PMID:23877478 PMID:24033266 PMID:24775816 PMID:24803665 PMID:25706034 PMID:25741868 PMID:26619011 PMID:26918529 PMID:27631234 PMID:28492532 PMID:28777121 PMID:28973083 PMID:28991257 PMID:29084544 PMID:29493581 PMID:29907801 PMID:30055033 PMID:30105547 PMID:30138938 PMID:30384889 PMID:30417923 PMID:30732632 PMID:31324109 PMID:31395954 PMID:31560489 PMID:32410215 PMID:32506814 PMID:32573669 PMID:32668055 PMID:32981126 PMID:33240318 PMID:33318624 PMID:33673806 PMID:34006472 PMID:34136434 PMID:35050212 More...
|
|
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
|
|
G |
Rangrf |
RAN guanine nucleotide release factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:53,677,467...53,678,880
Ensembl chr10:53,677,467...53,678,840
|
|
G |
Rarb |
retinoic acid receptor, beta |
|
ISO |
DNA:hypomethylation:lung |
RGD |
PMID:26695082 |
RGD:13464334 |
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
|
|
G |
Rasa1 |
RAS p21 protein activator 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27158780 |
|
NCBI chr 2:15,857,704...15,940,757
Ensembl chr 2:15,857,980...15,940,854
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rbm10 |
RNA binding motif protein 10 |
|
ISO |
mRNA, protein:decreased expression:lung DNA:missense mutations, protein-truncating variants: :multiple |
RGD |
PMID:29085465 PMID:22980975 PMID:30955253 |
RGD:151356983, RGD:11097386, RGD:151356984 |
NCBI chr X:1,540,399...1,572,571
Ensembl chr X:1,540,398...1,572,575
|
|
G |
Rcl1 |
RNA terminal phosphate cyclase-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:226,824,561...226,869,046
Ensembl chr 1:226,824,534...226,902,315
|
|
G |
Rfc4 |
replication factor C subunit 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr11:77,749,642...77,764,123
Ensembl chr11:77,749,638...77,764,122
|
|
G |
Rhoa |
ras homolog family member A |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:26619011 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Rin3 |
Ras and Rab interactor 3 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 6:121,431,776...121,540,956
Ensembl chr 6:121,431,339...121,540,957
|
|
G |
Rnaseh2a |
ribonuclease H2, subunit A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34254728 |
|
NCBI chr19:23,186,325...23,196,045
Ensembl chr19:23,186,383...23,196,041
|
|
G |
Rnf43 |
ring finger protein 43 |
severity |
ISO |
human cells in a mouse model |
RGD |
PMID:31286874 |
RGD:151361222 |
NCBI chr10:72,461,508...72,537,301
Ensembl chr10:72,464,348...72,536,977
|
|
G |
Ros1 |
ROS proto-oncogene 1 , receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Lung adenocarcinoma |
CTD ClinVar |
PMID:22215748 PMID:23724914 PMID:27993330 |
|
NCBI chr20:31,432,636...31,583,998
Ensembl chr20:31,432,637...31,583,865
|
|
G |
Rpl10a |
ribosomal protein L10A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr20:6,388,800...6,391,358
Ensembl chr20:6,385,823...6,391,357
|
|
G |
Rpl13a |
ribosomal protein L13A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:95,609,374...95,612,557
Ensembl chr 1:95,609,370...95,620,463
|
|
G |
Rpl27a |
ribosomal protein L27A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:163,539,732...163,542,771
|
|
G |
Rpl36a |
ribosomal protein L36A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr X:97,766,179...97,768,892
Ensembl chr X:97,766,179...97,768,892
|
|
G |
Rpsa |
ribosomal protein SA |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 8:119,851,225...119,855,103
Ensembl chr 8:119,851,225...119,855,247
|
|
G |
Rrm1 |
ribonucleotide reductase catalytic subunit M1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:156,823,960...156,848,262
Ensembl chr 1:156,823,960...156,848,261
|
|
G |
Rrm2 |
ribonucleotide reductase regulatory subunit M2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
|
|
G |
Rrs1 |
ribosome biogenesis regulator 1 homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 5:9,733,486...9,735,119
Ensembl chr 5:9,733,091...9,735,140
|
|
G |
Runx1 |
RUNX family transcription factor 1 |
|
ISO |
|
RGD |
PMID:28926105 |
RGD:126779571 |
NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542
|
|
G |
Satb1 |
SATB homeobox 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 9:4,677,817...4,773,061
Ensembl chr 9:4,680,920...4,753,251
|
|
G |
Sdc1 |
syndecan 1 |
|
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:23374247 |
RGD:151708716 |
NCBI chr 6:31,562,799...31,585,267
Ensembl chr 6:31,562,739...31,585,264
|
|
G |
Serpina3n |
serpin family A member 3N |
|
ISO |
protein:increased expression:cytoplasm |
RGD |
PMID:8620411 |
RGD:5147446 |
NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433
|
|
G |
Setd2 |
SET domain containing 2, histone lysine methyltransferase |
ameliorates exacerbates severity |
ISO |
human cells and genes in mouse model DNA:mutations:multiple (human) |
RGD |
PMID:33223508 PMID:27687306 PMID:33707235 PMID:28202515 |
RGD:150429633, RGD:150429649, RGD:150429648, RGD:126848875 |
NCBI chr 8:110,511,808...110,597,475
Ensembl chr 8:110,511,772...110,597,489
|
|
G |
Sfn |
stratifin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
|
|
G |
Sftpc |
surfactant protein C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25851810 |
|
NCBI chr15:45,596,565...45,599,615
Ensembl chr15:45,596,574...45,610,777
|
|
G |
Sfxn1 |
sideroflexin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr17:10,486,250...10,522,640
Ensembl chr17:10,486,271...10,522,529
|
|
G |
Shmt1 |
serine hydroxymethyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:45,468,698...45,490,833
Ensembl chr10:45,468,700...45,497,820
|
|
G |
Slc15a2 |
solute carrier family 15 member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr11:64,014,182...64,043,228
Ensembl chr11:64,014,182...64,043,225
|
|
G |
Slc19a1 |
solute carrier family 19 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr20:11,584,410...11,602,429
Ensembl chr20:11,584,411...11,601,972
|
|
G |
Slc1a5 |
solute carrier family 1 member 5 |
disease_progression |
ISO |
|
RGD |
PMID:26279756 |
RGD:151361150 |
NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952
|
|
G |
Slc22a18 |
solute carrier family 22, member 18 |
disease_progression |
ISO |
mRNA:increased expression:lung (human) ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar RGD |
PMID:27993330 PMID:32726996 |
RGD:150557423 |
NCBI chr 1:198,670,626...198,694,977
Ensembl chr 1:198,671,731...198,694,975
|
|
G |
Slc3a2 |
solute carrier family 3 member 2 |
disease_progression |
ISO |
|
RGD |
PMID:19171406 |
RGD:151361151 |
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
|
|
G |
Slc4a4 |
solute carrier family 4 member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr14:18,841,289...19,293,297
Ensembl chr14:18,845,159...19,272,883
|
|
G |
Slc4a7 |
solute carrier family 4 member 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr15:10,585,307...10,664,780
Ensembl chr15:10,588,979...10,664,781
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
disease_progression |
ISO |
|
RGD |
PMID:26279756 PMID:19171406 |
RGD:151361150, RGD:151361151 |
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
|
|
G |
Smad4 |
SMAD family member 4 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:6604412 PMID:8898652 PMID:9214508 PMID:9285566 PMID:9582123 PMID:9679244 PMID:9811934 PMID:10479724 PMID:10764709 PMID:10775259 PMID:10797267 PMID:11274206 PMID:11583957 PMID:12116240 PMID:12821112 PMID:14715079 PMID:15014009 PMID:15031030 PMID:15235019 PMID:15799969 PMID:16613914 PMID:17132729 PMID:17873119 PMID:17994767 PMID:18823382 PMID:20101697 PMID:20301642 PMID:22316667 PMID:22331366 PMID:25741868 PMID:26572829 PMID:26619011 PMID:26900293 PMID:27595937 PMID:28492532 PMID:31837202 PMID:32300199 PMID:32573726 PMID:32944796 PMID:33326750 More...
|
|
NCBI chr18:67,243,742...67,274,438
Ensembl chr18:67,243,742...67,274,438
|
|
G |
Smarcc1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 8:110,111,097...110,214,734
Ensembl chr 8:110,111,122...110,214,720
|
|
G |
Snord22 |
small nucleolar RNA, C/D box 22 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr11:9,097,799...9,097,923
Ensembl chr11:9,097,799...9,097,923
|
|
G |
Snrpb |
small nuclear ribonucleoprotein polypeptides B and B1 |
severity |
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:22876301 |
RGD:10768834 |
NCBI chr 3:117,369,816...117,379,344
Ensembl chr 3:117,370,100...117,379,339
|
|
G |
Snrpe |
small nuclear ribonucleoprotein polypeptide E |
severity |
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:22876301 |
RGD:10768834 |
NCBI chr13:45,050,986...45,057,231
Ensembl chr13:45,050,986...45,057,310 Ensembl chr 8:45,050,986...45,057,310
|
|
G |
Snrpg |
small nuclear ribonucleoprotein polypeptide G |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 4:118,812,278...118,819,827
Ensembl chr 4:118,812,252...118,819,826
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sos1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Lung adenocarcinoma |
CTD ClinVar |
PMID:25741868 PMID:26619011 PMID:27158780 |
|
NCBI chr 6:14,533,870...14,613,348
Ensembl chr 6:14,533,360...14,611,107
|
|
G |
Sox2 |
SRY-box transcription factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25184679 |
|
NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
|
|
G |
Sox30 |
SRY-box transcription factor 30 |
disease_progression |
ISO |
|
RGD |
PMID:26330328 |
RGD:11535423 |
NCBI chr10:30,417,499...30,446,441
Ensembl chr10:30,418,473...30,446,453
|
|
G |
Sox4 |
SRY-box transcription factor 4 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:29882245 |
RGD:153297792 |
NCBI chr17:35,667,809...35,672,515
Ensembl chr17:35,667,537...35,673,665
|
|
G |
Spop |
speckle type BTB/POZ protein |
ameliorates |
ISO |
human gene and cell line in mouse model mRNA, protein:increased expression:lung (human) |
RGD |
PMID:30607139 PMID:31105033 |
RGD:153298920, RGD:153298927 |
NCBI chr10:80,358,121...80,438,983
Ensembl chr10:80,358,124...80,483,955
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
severity |
ISO |
|
RGD |
PMID:12826049 |
RGD:150521546 |
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Srm |
spermidine synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 5:159,025,875...159,029,076
Ensembl chr 5:159,025,873...159,029,405
|
|
G |
Srr |
serine racemase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:59,769,563...59,786,688
Ensembl chr10:59,769,571...59,787,011
|
|
G |
Srsf1 |
serine and arginine rich splicing factor 1 |
severity |
ISO |
|
RGD |
PMID:23071587 |
RGD:150429662 |
NCBI chr10:72,838,926...72,859,066
Ensembl chr10:72,839,274...72,845,336
|
|
G |
Srsf2 |
serine and arginine rich splicing factor 2 |
severity |
ISO |
|
RGD |
PMID:23071587 |
RGD:150429662 |
NCBI chr10:102,052,158...102,055,365
Ensembl chr10:102,052,314...102,055,338
|
|
G |
Stk11 |
serine/threonine kinase 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Lung adenocarcinoma |
CTD ClinVar |
PMID:10408777 PMID:12865922 PMID:15561763 PMID:15863673 PMID:16287113 PMID:16582077 PMID:17026623 PMID:17676035 PMID:19892943 PMID:20393878 PMID:20435009 PMID:23399955 PMID:23718779 PMID:24793789 PMID:25157968 PMID:25226294 PMID:25741868 PMID:26056085 PMID:26467025 PMID:27081308 PMID:27993330 PMID:28152038 PMID:28492532 PMID:30528796 PMID:31159747 More...
|
|
NCBI chr 7:9,574,553...9,591,315
Ensembl chr 7:9,575,269...9,591,315
|
|
G |
Stk39 |
serine threonine kinase 39 |
|